TWI404546B - Coating composition - Google Patents
Coating composition Download PDFInfo
- Publication number
- TWI404546B TWI404546B TW97121436A TW97121436A TWI404546B TW I404546 B TWI404546 B TW I404546B TW 97121436 A TW97121436 A TW 97121436A TW 97121436 A TW97121436 A TW 97121436A TW I404546 B TWI404546 B TW I404546B
- Authority
- TW
- Taiwan
- Prior art keywords
- coating
- mass
- manufactured
- film
- coated
- Prior art date
Links
- 239000008199 coating composition Substances 0.000 title claims description 16
- 239000000203 mixture Substances 0.000 claims abstract description 42
- 239000000454 talc Substances 0.000 claims abstract description 31
- 229910052623 talc Inorganic materials 0.000 claims abstract description 31
- 238000002360 preparation method Methods 0.000 claims abstract description 28
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims abstract description 19
- 239000002202 Polyethylene glycol Substances 0.000 claims abstract description 16
- 229920001223 polyethylene glycol Polymers 0.000 claims abstract description 16
- 239000011248 coating agent Substances 0.000 claims description 101
- 238000000576 coating method Methods 0.000 claims description 98
- -1 hydroxypropoxyl Chemical group 0.000 claims description 48
- 239000007787 solid Substances 0.000 claims description 13
- 239000002245 particle Substances 0.000 claims description 11
- 239000003086 colorant Substances 0.000 claims description 6
- 238000006467 substitution reaction Methods 0.000 claims description 4
- GRVDJDISBSALJP-UHFFFAOYSA-N methyloxidanyl Chemical group [O]C GRVDJDISBSALJP-UHFFFAOYSA-N 0.000 claims 1
- 238000009495 sugar coating Methods 0.000 abstract description 9
- 239000007888 film coating Substances 0.000 abstract 1
- 238000009501 film coating Methods 0.000 abstract 1
- 239000007788 liquid Substances 0.000 description 51
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 26
- 239000008213 purified water Substances 0.000 description 25
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 21
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 20
- 229940093429 polyethylene glycol 6000 Drugs 0.000 description 16
- 239000000843 powder Substances 0.000 description 16
- 238000000034 method Methods 0.000 description 15
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 12
- 230000000052 comparative effect Effects 0.000 description 12
- 235000014113 dietary fatty acids Nutrition 0.000 description 12
- 239000000194 fatty acid Substances 0.000 description 12
- 229930195729 fatty acid Natural products 0.000 description 12
- HSHXDCVZWHOWCS-UHFFFAOYSA-N N'-hexadecylthiophene-2-carbohydrazide Chemical compound CCCCCCCCCCCCCCCCNNC(=O)c1cccs1 HSHXDCVZWHOWCS-UHFFFAOYSA-N 0.000 description 11
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 11
- 235000019441 ethanol Nutrition 0.000 description 11
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 11
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 11
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 10
- 239000000284 extract Substances 0.000 description 10
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 10
- 239000000126 substance Substances 0.000 description 10
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 8
- DOIRQSBPFJWKBE-UHFFFAOYSA-N dibutyl phthalate Chemical compound CCCCOC(=O)C1=CC=CC=C1C(=O)OCCCC DOIRQSBPFJWKBE-UHFFFAOYSA-N 0.000 description 8
- 238000009472 formulation Methods 0.000 description 8
- 229940031705 hydroxypropyl methylcellulose 2910 Drugs 0.000 description 8
- 239000008188 pellet Substances 0.000 description 8
- 239000001993 wax Substances 0.000 description 8
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 7
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 7
- 229960004543 anhydrous citric acid Drugs 0.000 description 7
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 7
- 229960002079 calcium pantothenate Drugs 0.000 description 7
- 239000004359 castor oil Substances 0.000 description 7
- 235000019438 castor oil Nutrition 0.000 description 7
- 229920002678 cellulose Polymers 0.000 description 7
- 239000001913 cellulose Substances 0.000 description 7
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 7
- 238000005469 granulation Methods 0.000 description 7
- 230000003179 granulation Effects 0.000 description 7
- 239000000546 pharmaceutical excipient Substances 0.000 description 7
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 6
- 239000004372 Polyvinyl alcohol Substances 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 6
- 239000003795 chemical substances by application Substances 0.000 description 6
- 235000011187 glycerol Nutrition 0.000 description 6
- 229940031703 low substituted hydroxypropyl cellulose Drugs 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- 239000003921 oil Substances 0.000 description 6
- 235000019198 oils Nutrition 0.000 description 6
- 229920002451 polyvinyl alcohol Polymers 0.000 description 6
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 6
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 5
- 244000215068 Acacia senegal Species 0.000 description 5
- 229920000084 Gum arabic Polymers 0.000 description 5
- 229930006000 Sucrose Natural products 0.000 description 5
- 235000010489 acacia gum Nutrition 0.000 description 5
- 239000000205 acacia gum Substances 0.000 description 5
- 239000000654 additive Substances 0.000 description 5
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 5
- 150000002009 diols Chemical group 0.000 description 5
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 5
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 5
- 238000003703 image analysis method Methods 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 5
- 235000019359 magnesium stearate Nutrition 0.000 description 5
- 229940117841 methacrylic acid copolymer Drugs 0.000 description 5
- 229920003145 methacrylic acid copolymer Polymers 0.000 description 5
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 5
- 229920001451 polypropylene glycol Polymers 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 4
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 4
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 4
- 229920001800 Shellac Polymers 0.000 description 4
- 235000021355 Stearic acid Nutrition 0.000 description 4
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 4
- 239000001768 carboxy methyl cellulose Substances 0.000 description 4
- 229960002380 dibutyl phthalate Drugs 0.000 description 4
- 235000019700 dicalcium phosphate Nutrition 0.000 description 4
- FLKPEMZONWLCSK-UHFFFAOYSA-N diethyl phthalate Chemical compound CCOC(=O)C1=CC=CC=C1C(=O)OCC FLKPEMZONWLCSK-UHFFFAOYSA-N 0.000 description 4
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 4
- 239000002270 dispersing agent Substances 0.000 description 4
- 239000008101 lactose Substances 0.000 description 4
- 239000002932 luster Substances 0.000 description 4
- 238000005065 mining Methods 0.000 description 4
- 239000011812 mixed powder Substances 0.000 description 4
- 239000004570 mortar (masonry) Substances 0.000 description 4
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 4
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 4
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 4
- 229920000053 polysorbate 80 Polymers 0.000 description 4
- 229940068968 polysorbate 80 Drugs 0.000 description 4
- 235000013772 propylene glycol Nutrition 0.000 description 4
- 239000004208 shellac Substances 0.000 description 4
- 229940113147 shellac Drugs 0.000 description 4
- ZLGIYFNHBLSMPS-ATJNOEHPSA-N shellac Chemical compound OCCCCCC(O)C(O)CCCCCCCC(O)=O.C1C23[C@H](C(O)=O)CCC2[C@](C)(CO)[C@@H]1C(C(O)=O)=C[C@@H]3O ZLGIYFNHBLSMPS-ATJNOEHPSA-N 0.000 description 4
- 235000013874 shellac Nutrition 0.000 description 4
- 239000008117 stearic acid Substances 0.000 description 4
- URAYPUMNDPQOKB-UHFFFAOYSA-N triacetin Chemical compound CC(=O)OCC(OC(C)=O)COC(C)=O URAYPUMNDPQOKB-UHFFFAOYSA-N 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 3
- 229920002261 Corn starch Polymers 0.000 description 3
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 3
- 239000001856 Ethyl cellulose Substances 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- 108010010803 Gelatin Proteins 0.000 description 3
- 239000004201 L-cysteine Substances 0.000 description 3
- 235000013878 L-cysteine Nutrition 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- 229920002125 Sokalan® Polymers 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 230000000996 additive effect Effects 0.000 description 3
- 229920003144 amino alkyl methacrylate copolymer Polymers 0.000 description 3
- 239000002518 antifoaming agent Substances 0.000 description 3
- 235000010323 ascorbic acid Nutrition 0.000 description 3
- 239000011668 ascorbic acid Substances 0.000 description 3
- 229960005070 ascorbic acid Drugs 0.000 description 3
- 235000013339 cereals Nutrition 0.000 description 3
- 229910000420 cerium oxide Inorganic materials 0.000 description 3
- 229920001577 copolymer Polymers 0.000 description 3
- 239000008120 corn starch Substances 0.000 description 3
- 238000013461 design Methods 0.000 description 3
- 239000006185 dispersion Substances 0.000 description 3
- 235000019325 ethyl cellulose Nutrition 0.000 description 3
- 229920001249 ethyl cellulose Polymers 0.000 description 3
- FVTCRASFADXXNN-SCRDCRAPSA-N flavin mononucleotide Chemical compound OP(=O)(O)OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O FVTCRASFADXXNN-SCRDCRAPSA-N 0.000 description 3
- 239000008273 gelatin Substances 0.000 description 3
- 229920000159 gelatin Polymers 0.000 description 3
- 235000019322 gelatine Nutrition 0.000 description 3
- 235000011852 gelatine desserts Nutrition 0.000 description 3
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 3
- 229940057995 liquid paraffin Drugs 0.000 description 3
- 239000011777 magnesium Substances 0.000 description 3
- 239000013521 mastic Substances 0.000 description 3
- 229920000609 methyl cellulose Polymers 0.000 description 3
- 239000001923 methylcellulose Substances 0.000 description 3
- BMMGVYCKOGBVEV-UHFFFAOYSA-N oxo(oxoceriooxy)cerium Chemical compound [Ce]=O.O=[Ce]=O BMMGVYCKOGBVEV-UHFFFAOYSA-N 0.000 description 3
- 239000000825 pharmaceutical preparation Substances 0.000 description 3
- 229940127557 pharmaceutical product Drugs 0.000 description 3
- 239000004014 plasticizer Substances 0.000 description 3
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 3
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- 230000002335 preservative effect Effects 0.000 description 3
- 229950001574 riboflavin phosphate Drugs 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 229960002920 sorbitol Drugs 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- 229920002554 vinyl polymer Polymers 0.000 description 3
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 2
- PZNPLUBHRSSFHT-RRHRGVEJSA-N 1-hexadecanoyl-2-octadecanoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCCCC(=O)O[C@@H](COP([O-])(=O)OCC[N+](C)(C)C)COC(=O)CCCCCCCCCCCCCCC PZNPLUBHRSSFHT-RRHRGVEJSA-N 0.000 description 2
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 2
- XZIIFPSPUDAGJM-UHFFFAOYSA-N 6-chloro-2-n,2-n-diethylpyrimidine-2,4-diamine Chemical compound CCN(CC)C1=NC(N)=CC(Cl)=N1 XZIIFPSPUDAGJM-UHFFFAOYSA-N 0.000 description 2
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 2
- RSWGJHLUYNHPMX-UHFFFAOYSA-N Abietic-Saeure Natural products C12CCC(C(C)C)=CC2=CCC2C1(C)CCCC2(C)C(O)=O RSWGJHLUYNHPMX-UHFFFAOYSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 2
- 229920002785 Croscarmellose sodium Polymers 0.000 description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- 241000545744 Hirudinea Species 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 239000005642 Oleic acid Substances 0.000 description 2
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- MJNIWUJSIGSWKK-BBANNHEPSA-N Riboflavin butyrate Chemical compound CCCC(=O)OC[C@@H](OC(=O)CCC)[C@@H](OC(=O)CCC)[C@@H](OC(=O)CCC)CN1C2=CC(C)=C(C)C=C2N=C2C1=NC(=O)NC2=O MJNIWUJSIGSWKK-BBANNHEPSA-N 0.000 description 2
- KHPCPRHQVVSZAH-HUOMCSJISA-N Rosin Natural products O(C/C=C/c1ccccc1)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 KHPCPRHQVVSZAH-HUOMCSJISA-N 0.000 description 2
- 239000004147 Sorbitan trioleate Substances 0.000 description 2
- PRXRUNOAOLTIEF-ADSICKODSA-N Sorbitan trioleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCC\C=C/CCCCCCCC)[C@H]1OC[C@H](O)[C@H]1OC(=O)CCCCCCC\C=C/CCCCCCCC PRXRUNOAOLTIEF-ADSICKODSA-N 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
- DOOTYTYQINUNNV-UHFFFAOYSA-N Triethyl citrate Chemical compound CCOC(=O)CC(O)(C(=O)OCC)CC(=O)OCC DOOTYTYQINUNNV-UHFFFAOYSA-N 0.000 description 2
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 239000000440 bentonite Substances 0.000 description 2
- 229910000278 bentonite Inorganic materials 0.000 description 2
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 2
- 229960002685 biotin Drugs 0.000 description 2
- 235000020958 biotin Nutrition 0.000 description 2
- 239000011616 biotin Substances 0.000 description 2
- MKJXYGKVIBWPFZ-UHFFFAOYSA-L calcium lactate Chemical compound [Ca+2].CC(O)C([O-])=O.CC(O)C([O-])=O MKJXYGKVIBWPFZ-UHFFFAOYSA-L 0.000 description 2
- 239000001527 calcium lactate Substances 0.000 description 2
- 229960002401 calcium lactate Drugs 0.000 description 2
- 235000011086 calcium lactate Nutrition 0.000 description 2
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 2
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 2
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 2
- 239000007765 cera alba Substances 0.000 description 2
- 229960004106 citric acid Drugs 0.000 description 2
- 235000015165 citric acid Nutrition 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 229960001681 croscarmellose sodium Drugs 0.000 description 2
- 235000010947 crosslinked sodium carboxy methyl cellulose Nutrition 0.000 description 2
- RMRCNWBMXRMIRW-BYFNXCQMSA-M cyanocobalamin Chemical compound N#C[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O RMRCNWBMXRMIRW-BYFNXCQMSA-M 0.000 description 2
- 230000001877 deodorizing effect Effects 0.000 description 2
- UGMCXQCYOVCMTB-UHFFFAOYSA-K dihydroxy(stearato)aluminium Chemical compound CCCCCCCCCCCCCCCCCC(=O)O[Al](O)O UGMCXQCYOVCMTB-UHFFFAOYSA-K 0.000 description 2
- 239000000428 dust Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 235000013355 food flavoring agent Nutrition 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 229940075507 glyceryl monostearate Drugs 0.000 description 2
- 239000001087 glyceryl triacetate Substances 0.000 description 2
- 235000013773 glyceryl triacetate Nutrition 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 239000010440 gypsum Substances 0.000 description 2
- 229910052602 gypsum Inorganic materials 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N iron oxide Inorganic materials [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 2
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 2
- 239000004922 lacquer Substances 0.000 description 2
- 239000000314 lubricant Substances 0.000 description 2
- 239000004337 magnesium citrate Substances 0.000 description 2
- 229960005336 magnesium citrate Drugs 0.000 description 2
- 235000002538 magnesium citrate Nutrition 0.000 description 2
- 235000010981 methylcellulose Nutrition 0.000 description 2
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 2
- NDLPOXTZKUMGOV-UHFFFAOYSA-N oxo(oxoferriooxy)iron hydrate Chemical compound O.O=[Fe]O[Fe]=O NDLPOXTZKUMGOV-UHFFFAOYSA-N 0.000 description 2
- 239000002304 perfume Substances 0.000 description 2
- 229920000223 polyglycerol Polymers 0.000 description 2
- 229920001592 potato starch Polymers 0.000 description 2
- 229940069328 povidone Drugs 0.000 description 2
- 239000002987 primer (paints) Substances 0.000 description 2
- NGVDGCNFYWLIFO-UHFFFAOYSA-N pyridoxal 5'-phosphate Chemical compound CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O NGVDGCNFYWLIFO-UHFFFAOYSA-N 0.000 description 2
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 2
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 description 2
- 239000011764 pyridoxine hydrochloride Substances 0.000 description 2
- 229960004172 pyridoxine hydrochloride Drugs 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 238000007127 saponification reaction Methods 0.000 description 2
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 2
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 2
- 235000011121 sodium hydroxide Nutrition 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 229940035044 sorbitan monolaurate Drugs 0.000 description 2
- 235000019337 sorbitan trioleate Nutrition 0.000 description 2
- 229960000391 sorbitan trioleate Drugs 0.000 description 2
- 239000003549 soybean oil Substances 0.000 description 2
- 235000012424 soybean oil Nutrition 0.000 description 2
- 239000008347 soybean phospholipid Substances 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 229910021653 sulphate ion Inorganic materials 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- HLZKNKRTKFSKGZ-UHFFFAOYSA-N tetradecan-1-ol Chemical compound CCCCCCCCCCCCCCO HLZKNKRTKFSKGZ-UHFFFAOYSA-N 0.000 description 2
- UIERGBJEBXXIGO-UHFFFAOYSA-N thiamine mononitrate Chemical compound [O-][N+]([O-])=O.CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N UIERGBJEBXXIGO-UHFFFAOYSA-N 0.000 description 2
- KHPCPRHQVVSZAH-UHFFFAOYSA-N trans-cinnamyl beta-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OCC=CC1=CC=CC=C1 KHPCPRHQVVSZAH-UHFFFAOYSA-N 0.000 description 2
- 229960002622 triacetin Drugs 0.000 description 2
- 239000001069 triethyl citrate Substances 0.000 description 2
- VMYFZRTXGLUXMZ-UHFFFAOYSA-N triethyl citrate Natural products CCOC(=O)C(O)(C(=O)OCC)C(=O)OCC VMYFZRTXGLUXMZ-UHFFFAOYSA-N 0.000 description 2
- 235000013769 triethyl citrate Nutrition 0.000 description 2
- PLSARIKBYIPYPF-UHFFFAOYSA-H trimagnesium dicitrate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O PLSARIKBYIPYPF-UHFFFAOYSA-H 0.000 description 2
- DTGKSKDOIYIVQL-NQMVMOMDSA-N (+)-Borneol Natural products C1C[C@]2(C)[C@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-NQMVMOMDSA-N 0.000 description 1
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 1
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 description 1
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- RUDATBOHQWOJDD-UHFFFAOYSA-N (3beta,5beta,7alpha)-3,7-Dihydroxycholan-24-oic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)CC2 RUDATBOHQWOJDD-UHFFFAOYSA-N 0.000 description 1
- LNOLJFCCYQZFBQ-BUHFOSPRSA-N (ne)-n-[(4-nitrophenyl)-phenylmethylidene]hydroxylamine Chemical compound C=1C=C([N+]([O-])=O)C=CC=1C(=N/O)/C1=CC=CC=C1 LNOLJFCCYQZFBQ-BUHFOSPRSA-N 0.000 description 1
- ZORQXIQZAOLNGE-UHFFFAOYSA-N 1,1-difluorocyclohexane Chemical compound FC1(F)CCCCC1 ZORQXIQZAOLNGE-UHFFFAOYSA-N 0.000 description 1
- VZXTWGWHSMCWGA-UHFFFAOYSA-N 1,3,5-triazine-2,4-diamine Chemical compound NC1=NC=NC(N)=N1 VZXTWGWHSMCWGA-UHFFFAOYSA-N 0.000 description 1
- CUOSYYRDANYHTL-UHFFFAOYSA-N 1,4-dioctoxy-1,4-dioxobutane-2-sulfonic acid;sodium Chemical compound [Na].CCCCCCCCOC(=O)CC(S(O)(=O)=O)C(=O)OCCCCCCCC CUOSYYRDANYHTL-UHFFFAOYSA-N 0.000 description 1
- CIVCELMLGDGMKZ-UHFFFAOYSA-N 2,4-dichloro-6-methylpyridine-3-carboxylic acid Chemical compound CC1=CC(Cl)=C(C(O)=O)C(Cl)=N1 CIVCELMLGDGMKZ-UHFFFAOYSA-N 0.000 description 1
- JKNCOURZONDCGV-UHFFFAOYSA-N 2-(dimethylamino)ethyl 2-methylprop-2-enoate Chemical compound CN(C)CCOC(=O)C(C)=C JKNCOURZONDCGV-UHFFFAOYSA-N 0.000 description 1
- PWKSKIMOESPYIA-UHFFFAOYSA-N 2-acetamido-3-sulfanylpropanoic acid Chemical compound CC(=O)NC(CS)C(O)=O PWKSKIMOESPYIA-UHFFFAOYSA-N 0.000 description 1
- UBVSIAHUTXHQTD-UHFFFAOYSA-N 2-n-(4-bromophenyl)-1,3,5-triazine-2,4-diamine Chemical compound NC1=NC=NC(NC=2C=CC(Br)=CC=2)=N1 UBVSIAHUTXHQTD-UHFFFAOYSA-N 0.000 description 1
- BGRXBNZMPMGLQI-UHFFFAOYSA-N 2-octyldodecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(CCCCCCCC)CCCCCCCCCC BGRXBNZMPMGLQI-UHFFFAOYSA-N 0.000 description 1
- MIDXCONKKJTLDX-UHFFFAOYSA-N 3,5-dimethylcyclopentane-1,2-dione Chemical compound CC1CC(C)C(=O)C1=O MIDXCONKKJTLDX-UHFFFAOYSA-N 0.000 description 1
- MOMKYJPSVWEWPM-UHFFFAOYSA-N 4-(chloromethyl)-2-(4-methylphenyl)-1,3-thiazole Chemical compound C1=CC(C)=CC=C1C1=NC(CCl)=CS1 MOMKYJPSVWEWPM-UHFFFAOYSA-N 0.000 description 1
- NZVGXJAQIQJIOY-UHFFFAOYSA-N 4-[6-[6-(4-methylpiperazin-1-yl)-1h-benzimidazol-2-yl]-1h-benzimidazol-2-yl]benzenesulfonamide;trihydrochloride Chemical compound Cl.Cl.Cl.C1CN(C)CCN1C1=CC=C(N=C(N2)C=3C=C4NC(=NC4=CC=3)C=3C=CC(=CC=3)S(N)(=O)=O)C2=C1 NZVGXJAQIQJIOY-UHFFFAOYSA-N 0.000 description 1
- IELOKBJPULMYRW-IKTKBOKFSA-N 4-oxo-4-[[(2S)-2,5,7,8-tetramethyl-2-[(4S,8S)-4,8,12-trimethyltridecyl]-3,4-dihydrochromen-6-yl]oxy]butanoic acid Chemical compound CC(C)CCC[C@H](C)CCC[C@H](C)CCC[C@@](C)(CC1)Oc(c(C)c2C)c1c(C)c2OC(CCC(O)=O)=O IELOKBJPULMYRW-IKTKBOKFSA-N 0.000 description 1
- ZUGAOYSWHHGDJY-UHFFFAOYSA-K 5-hydroxy-2,8,9-trioxa-1-aluminabicyclo[3.3.2]decane-3,7,10-trione Chemical compound [Al+3].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O ZUGAOYSWHHGDJY-UHFFFAOYSA-K 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N Alumina Chemical compound [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- WLDHEUZGFKACJH-ZRUFZDNISA-K Amaranth Chemical compound [Na+].[Na+].[Na+].C12=CC=C(S([O-])(=O)=O)C=C2C=C(S([O-])(=O)=O)C(O)=C1\N=N\C1=CC=C(S([O-])(=O)=O)C2=CC=CC=C12 WLDHEUZGFKACJH-ZRUFZDNISA-K 0.000 description 1
- 241000271309 Aquilaria crassna Species 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- 208000000659 Autoimmune lymphoproliferative syndrome Diseases 0.000 description 1
- 240000008564 Boehmeria nivea Species 0.000 description 1
- SGHZXLIDFTYFHQ-UHFFFAOYSA-L Brilliant Blue Chemical compound [Na+].[Na+].C=1C=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C(=CC=CC=2)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=CC(S([O-])(=O)=O)=C1 SGHZXLIDFTYFHQ-UHFFFAOYSA-L 0.000 description 1
- 241000202726 Bupleurum Species 0.000 description 1
- FIPWRIJSWJWJAI-UHFFFAOYSA-N Butyl carbitol 6-propylpiperonyl ether Chemical compound C1=C(CCC)C(COCCOCCOCCCC)=CC2=C1OCO2 FIPWRIJSWJWJAI-UHFFFAOYSA-N 0.000 description 1
- GOJCZVPJCKEBQV-UHFFFAOYSA-N Butyl phthalyl butylglycolate Chemical compound CCCCOC(=O)COC(=O)C1=CC=CC=C1C(=O)OCCCC GOJCZVPJCKEBQV-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 244000077995 Coix lacryma jobi Species 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- IELOKBJPULMYRW-NJQVLOCASA-N D-alpha-Tocopheryl Acid Succinate Chemical compound OC(=O)CCC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C IELOKBJPULMYRW-NJQVLOCASA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- LKDRXBCSQODPBY-IANNHFEVSA-N D-sorbose Chemical compound OCC1(O)OC[C@@H](O)[C@H](O)[C@H]1O LKDRXBCSQODPBY-IANNHFEVSA-N 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N DL-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- 235000001809 DL-alpha-tocopherylacetate Nutrition 0.000 description 1
- 239000011626 DL-alpha-tocopherylacetate Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical group [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 1
- 241001632410 Eleutherococcus senticosus Species 0.000 description 1
- JIGUQPWFLRLWPJ-UHFFFAOYSA-N Ethyl acrylate Chemical compound CCOC(=O)C=C JIGUQPWFLRLWPJ-UHFFFAOYSA-N 0.000 description 1
- 241001289529 Fallopia multiflora Species 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 1
- LKDRXBCSQODPBY-AMVSKUEXSA-N L-(-)-Sorbose Chemical compound OCC1(O)OC[C@H](O)[C@@H](O)[C@@H]1O LKDRXBCSQODPBY-AMVSKUEXSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- 240000002624 Mespilus germanica Species 0.000 description 1
- 235000017784 Mespilus germanica Nutrition 0.000 description 1
- 235000000560 Mimusops elengi Nutrition 0.000 description 1
- SGXDXUYKISDCAZ-UHFFFAOYSA-N N,N-diethylglycine Chemical compound CCN(CC)CC(O)=O SGXDXUYKISDCAZ-UHFFFAOYSA-N 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- NEZSMMNVXVJSQK-UHFFFAOYSA-N OS([O-])(=O)=O.[PH3+]C1=CC=CC=C1 Chemical compound OS([O-])(=O)=O.[PH3+]C1=CC=CC=C1 NEZSMMNVXVJSQK-UHFFFAOYSA-N 0.000 description 1
- LGRFSURHDFAFJT-UHFFFAOYSA-N Phthalic anhydride Natural products C1=CC=C2C(=O)OC(=O)C2=C1 LGRFSURHDFAFJT-UHFFFAOYSA-N 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 229920002675 Polyoxyl Polymers 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- HDSBZMRLPLPFLQ-UHFFFAOYSA-N Propylene glycol alginate Chemical compound OC1C(O)C(OC)OC(C(O)=O)C1OC1C(O)C(O)C(C)C(C(=O)OCC(C)O)O1 HDSBZMRLPLPFLQ-UHFFFAOYSA-N 0.000 description 1
- 108010009736 Protein Hydrolysates Proteins 0.000 description 1
- 244000179560 Prunella vulgaris Species 0.000 description 1
- 235000010674 Prunella vulgaris Nutrition 0.000 description 1
- SAKWCOORWPANKM-UHFFFAOYSA-L S(=O)(=O)([O-])[O-].[NH4+].O[Co+] Chemical compound S(=O)(=O)([O-])[O-].[NH4+].O[Co+] SAKWCOORWPANKM-UHFFFAOYSA-L 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- IYFATESGLOUGBX-YVNJGZBMSA-N Sorbitan monopalmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O IYFATESGLOUGBX-YVNJGZBMSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 235000007837 Vangueria infausta Nutrition 0.000 description 1
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- MECHNRXZTMCUDQ-UHFFFAOYSA-N Vitamin D2 Natural products C1CCC2(C)C(C(C)C=CC(C)C(C)C)CCC2C1=CC=C1CC(O)CCC1=C MECHNRXZTMCUDQ-UHFFFAOYSA-N 0.000 description 1
- 239000005862 Whey Substances 0.000 description 1
- 102000007544 Whey Proteins Human genes 0.000 description 1
- 108010046377 Whey Proteins Proteins 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 229920002494 Zein Polymers 0.000 description 1
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 description 1
- 150000001241 acetals Chemical class 0.000 description 1
- GAMPNQJDUFQVQO-UHFFFAOYSA-N acetic acid;phthalic acid Chemical compound CC(O)=O.OC(=O)C1=CC=CC=C1C(O)=O GAMPNQJDUFQVQO-UHFFFAOYSA-N 0.000 description 1
- 229940081735 acetylcellulose Drugs 0.000 description 1
- 239000008186 active pharmaceutical agent Substances 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- IAJILQKETJEXLJ-QTBDOELSSA-N aldehydo-D-glucuronic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-QTBDOELSSA-N 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- CEGOLXSVJUTHNZ-UHFFFAOYSA-K aluminium tristearate Chemical compound [Al+3].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CEGOLXSVJUTHNZ-UHFFFAOYSA-K 0.000 description 1
- 229940024546 aluminum hydroxide gel Drugs 0.000 description 1
- 229940063655 aluminum stearate Drugs 0.000 description 1
- SMYKVLBUSSNXMV-UHFFFAOYSA-K aluminum;trihydroxide;hydrate Chemical compound O.[OH-].[OH-].[OH-].[Al+3] SMYKVLBUSSNXMV-UHFFFAOYSA-K 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 229960003589 arginine hydrochloride Drugs 0.000 description 1
- 230000002567 autonomic effect Effects 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 229940092738 beeswax Drugs 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- UXLGPJLQZVPSSD-UHFFFAOYSA-N bis(2-methylpropyl) sulfate Chemical compound CC(C)COS(=O)(=O)OCC(C)C UXLGPJLQZVPSSD-UHFFFAOYSA-N 0.000 description 1
- 229910052797 bismuth Inorganic materials 0.000 description 1
- JCXGWMGPZLAOME-UHFFFAOYSA-N bismuth atom Chemical compound [Bi] JCXGWMGPZLAOME-UHFFFAOYSA-N 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 229940067573 brown iron oxide Drugs 0.000 description 1
- JHIWVOJDXOSYLW-UHFFFAOYSA-N butyl 2,2-difluorocyclopropane-1-carboxylate Chemical compound CCCCOC(=O)C1CC1(F)F JHIWVOJDXOSYLW-UHFFFAOYSA-N 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229960005069 calcium Drugs 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011692 calcium ascorbate Substances 0.000 description 1
- 235000010376 calcium ascorbate Nutrition 0.000 description 1
- 229940047036 calcium ascorbate Drugs 0.000 description 1
- YYRMJZQKEFZXMX-UHFFFAOYSA-L calcium bis(dihydrogenphosphate) Chemical compound [Ca+2].OP(O)([O-])=O.OP(O)([O-])=O YYRMJZQKEFZXMX-UHFFFAOYSA-L 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 229940062672 calcium dihydrogen phosphate Drugs 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 1
- 239000008116 calcium stearate Substances 0.000 description 1
- 235000013539 calcium stearate Nutrition 0.000 description 1
- BLORRZQTHNGFTI-ZZMNMWMASA-L calcium-L-ascorbate Chemical compound [Ca+2].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] BLORRZQTHNGFTI-ZZMNMWMASA-L 0.000 description 1
- 235000013736 caramel Nutrition 0.000 description 1
- 239000006229 carbon black Substances 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 229960001777 castor oil Drugs 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- 229920002301 cellulose acetate Polymers 0.000 description 1
- CETPSERCERDGAM-UHFFFAOYSA-N ceric oxide Chemical compound O=[Ce]=O CETPSERCERDGAM-UHFFFAOYSA-N 0.000 description 1
- 229910000422 cerium(IV) oxide Inorganic materials 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- 235000019868 cocoa butter Nutrition 0.000 description 1
- 229940110456 cocoa butter Drugs 0.000 description 1
- 239000000571 coke Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 239000002826 coolant Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- YXMMAVURUUXKKN-UHFFFAOYSA-J copper chlorophyll sodium Chemical compound [Na+].[Na+].[Cu+2].[N-]1C2=C(C=3C(C(C)C(=CC=4C(=C(C=C)C(=C5)N=4)C)N=3)CCC([O-])=O)C(C([O-])=O)C([O-])=C2C(C)=C1C=C1C(CC)=C(C)C5=N1 YXMMAVURUUXKKN-UHFFFAOYSA-J 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 235000000639 cyanocobalamin Nutrition 0.000 description 1
- 239000011666 cyanocobalamin Substances 0.000 description 1
- 229960002104 cyanocobalamin Drugs 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 1
- 239000013530 defoamer Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- XLIDPNGFCHXNGX-UHFFFAOYSA-N dialuminum;oxygen(2-);silicon(4+) Chemical compound [O-2].[O-2].[O-2].[O-2].[O-2].[Al+3].[Al+3].[Si+4] XLIDPNGFCHXNGX-UHFFFAOYSA-N 0.000 description 1
- 229960000525 diphenhydramine hydrochloride Drugs 0.000 description 1
- 238000007907 direct compression Methods 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 229910000397 disodium phosphate Inorganic materials 0.000 description 1
- 235000019800 disodium phosphate Nutrition 0.000 description 1
- 229940117373 dl-alpha tocopheryl acetate Drugs 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 229940088679 drug related substance Drugs 0.000 description 1
- 238000007908 dry granulation Methods 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 235000020696 epimedium extract Nutrition 0.000 description 1
- 229960002061 ergocalciferol Drugs 0.000 description 1
- 235000012732 erythrosine Nutrition 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000004088 foaming agent Substances 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 229960002598 fumaric acid Drugs 0.000 description 1
- FODTZLFLDFKIQH-FSVGXZBPSA-N gamma-Oryzanol (TN) Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)O[C@@H]2C([C@@H]3CC[C@H]4[C@]5(C)CC[C@@H]([C@@]5(C)CC[C@@]54C[C@@]53CC2)[C@H](C)CCC=C(C)C)(C)C)=C1 FODTZLFLDFKIQH-FSVGXZBPSA-N 0.000 description 1
- 230000004313 glare Effects 0.000 description 1
- 229960001031 glucose Drugs 0.000 description 1
- 229940097043 glucuronic acid Drugs 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 239000001685 glycyrrhizic acid Substances 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 235000009569 green tea Nutrition 0.000 description 1
- 229940116364 hard fat Drugs 0.000 description 1
- 235000020717 hawthorn extract Nutrition 0.000 description 1
- WPEXVRDUEAJUGY-UHFFFAOYSA-B hexacalcium;(2,3,4,5,6-pentaphosphonatooxycyclohexyl) phosphate Chemical compound [Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])(=O)OC1C(OP([O-])([O-])=O)C(OP([O-])([O-])=O)C(OP([O-])([O-])=O)C(OP([O-])([O-])=O)C1OP([O-])([O-])=O WPEXVRDUEAJUGY-UHFFFAOYSA-B 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- NOVHEGOWZNFVGT-UHFFFAOYSA-N hydrazine Chemical compound NN.NN NOVHEGOWZNFVGT-UHFFFAOYSA-N 0.000 description 1
- 239000001341 hydroxy propyl starch Substances 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 229940031702 hydroxypropyl methylcellulose 2208 Drugs 0.000 description 1
- 229940031704 hydroxypropyl methylcellulose phthalate Drugs 0.000 description 1
- 229920003132 hydroxypropyl methylcellulose phthalate Polymers 0.000 description 1
- 235000013828 hydroxypropyl starch Nutrition 0.000 description 1
- 229940071676 hydroxypropylcellulose Drugs 0.000 description 1
- 229960001680 ibuprofen Drugs 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- WTFXARWRTYJXII-UHFFFAOYSA-N iron(2+);iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[Fe+2].[Fe+3].[Fe+3] WTFXARWRTYJXII-UHFFFAOYSA-N 0.000 description 1
- SZVJSHCCFOBDDC-UHFFFAOYSA-N iron(II,III) oxide Inorganic materials O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 239000007951 isotonicity adjuster Substances 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 229960001375 lactose Drugs 0.000 description 1
- 229940069445 licorice extract Drugs 0.000 description 1
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 239000000395 magnesium oxide Substances 0.000 description 1
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N malic acid Chemical compound OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- JEWJRMKHSMTXPP-BYFNXCQMSA-M methylcobalamin Chemical compound C[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O JEWJRMKHSMTXPP-BYFNXCQMSA-M 0.000 description 1
- 239000011585 methylcobalamin Substances 0.000 description 1
- 235000007672 methylcobalamin Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 235000019691 monocalcium phosphate Nutrition 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 239000004206 montan acid ester Substances 0.000 description 1
- 235000013872 montan acid ester Nutrition 0.000 description 1
- 229940043348 myristyl alcohol Drugs 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 229960002715 nicotine Drugs 0.000 description 1
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- UTOPWMOLSKOLTQ-UHFFFAOYSA-N octacosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCC(O)=O UTOPWMOLSKOLTQ-UHFFFAOYSA-N 0.000 description 1
- 229940073665 octyldodecyl myristate Drugs 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000007968 orange flavor Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- PNJWIWWMYCMZRO-UHFFFAOYSA-N pent‐4‐en‐2‐one Natural products CC(=O)CC=C PNJWIWWMYCMZRO-UHFFFAOYSA-N 0.000 description 1
- 238000011170 pharmaceutical development Methods 0.000 description 1
- 229960005235 piperonyl butoxide Drugs 0.000 description 1
- 238000006068 polycondensation reaction Methods 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229940113116 polyethylene glycol 1000 Drugs 0.000 description 1
- 229940093430 polyethylene glycol 1500 Drugs 0.000 description 1
- 229940113115 polyethylene glycol 200 Drugs 0.000 description 1
- 229940068918 polyethylene glycol 400 Drugs 0.000 description 1
- 229940057847 polyethylene glycol 600 Drugs 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 1
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 1
- 229940068977 polysorbate 20 Drugs 0.000 description 1
- 229940113124 polysorbate 60 Drugs 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229940116317 potato starch Drugs 0.000 description 1
- 229940088417 precipitated calcium carbonate Drugs 0.000 description 1
- 235000010409 propane-1,2-diol alginate Nutrition 0.000 description 1
- 239000000770 propane-1,2-diol alginate Substances 0.000 description 1
- 235000007682 pyridoxal 5'-phosphate Nutrition 0.000 description 1
- 239000011589 pyridoxal 5'-phosphate Substances 0.000 description 1
- 229960001327 pyridoxal phosphate Drugs 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 229940100486 rice starch Drugs 0.000 description 1
- 235000019719 rose oil Nutrition 0.000 description 1
- 239000010666 rose oil Substances 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- PPASLZSBLFJQEF-RKJRWTFHSA-M sodium ascorbate Substances [Na+].OC[C@@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RKJRWTFHSA-M 0.000 description 1
- 235000010378 sodium ascorbate Nutrition 0.000 description 1
- 229960005055 sodium ascorbate Drugs 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 235000011083 sodium citrates Nutrition 0.000 description 1
- FQENQNTWSFEDLI-UHFFFAOYSA-J sodium diphosphate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])([O-])=O FQENQNTWSFEDLI-UHFFFAOYSA-J 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 235000019983 sodium metaphosphate Nutrition 0.000 description 1
- 229940048086 sodium pyrophosphate Drugs 0.000 description 1
- PPASLZSBLFJQEF-RXSVEWSESA-M sodium-L-ascorbate Chemical compound [Na+].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RXSVEWSESA-M 0.000 description 1
- 235000011069 sorbitan monooleate Nutrition 0.000 description 1
- 239000001593 sorbitan monooleate Substances 0.000 description 1
- 229940035049 sorbitan monooleate Drugs 0.000 description 1
- 235000011071 sorbitan monopalmitate Nutrition 0.000 description 1
- 239000001570 sorbitan monopalmitate Substances 0.000 description 1
- 229940031953 sorbitan monopalmitate Drugs 0.000 description 1
- 238000004528 spin coating Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- VOKWSYFVHPBYBW-UHFFFAOYSA-N sulfuric acid hydrochloride Chemical compound S(O)(O)(=O)=O.S(O)(O)(=O)=O.Cl VOKWSYFVHPBYBW-UHFFFAOYSA-N 0.000 description 1
- 239000001117 sulphuric acid Substances 0.000 description 1
- 235000011149 sulphuric acid Nutrition 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 235000019818 tetrasodium diphosphate Nutrition 0.000 description 1
- 239000001577 tetrasodium phosphonato phosphate Substances 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 229960000344 thiamine hydrochloride Drugs 0.000 description 1
- 235000019190 thiamine hydrochloride Nutrition 0.000 description 1
- 239000011747 thiamine hydrochloride Substances 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 229940078499 tricalcium phosphate Drugs 0.000 description 1
- 229910000391 tricalcium phosphate Inorganic materials 0.000 description 1
- 235000019731 tricalcium phosphate Nutrition 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- UJMBCXLDXJUMFB-UHFFFAOYSA-K trisodium;5-oxo-1-(4-sulfonatophenyl)-4-[(4-sulfonatophenyl)diazenyl]-4h-pyrazole-3-carboxylate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)C1=NN(C=2C=CC(=CC=2)S([O-])(=O)=O)C(=O)C1N=NC1=CC=C(S([O-])(=O)=O)C=C1 UJMBCXLDXJUMFB-UHFFFAOYSA-K 0.000 description 1
- 239000008513 turmeric extract Substances 0.000 description 1
- 229940052016 turmeric extract Drugs 0.000 description 1
- 235000020240 turmeric extract Nutrition 0.000 description 1
- 238000010977 unit operation Methods 0.000 description 1
- RUDATBOHQWOJDD-UZVSRGJWSA-N ursodeoxycholic acid Chemical compound C([C@H]1C[C@@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)CC1 RUDATBOHQWOJDD-UZVSRGJWSA-N 0.000 description 1
- 229960001661 ursodiol Drugs 0.000 description 1
- 229940117958 vinyl acetate Drugs 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 235000001892 vitamin D2 Nutrition 0.000 description 1
- 239000011653 vitamin D2 Substances 0.000 description 1
- MECHNRXZTMCUDQ-RKHKHRCZSA-N vitamin D2 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)/C=C/[C@H](C)C(C)C)=C\C=C1\C[C@@H](O)CCC1=C MECHNRXZTMCUDQ-RKHKHRCZSA-N 0.000 description 1
- 235000005282 vitamin D3 Nutrition 0.000 description 1
- 239000011647 vitamin D3 Substances 0.000 description 1
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 229940021056 vitamin d3 Drugs 0.000 description 1
- 238000005550 wet granulation Methods 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 229940100445 wheat starch Drugs 0.000 description 1
- 229940093612 zein Drugs 0.000 description 1
- 239000005019 zein Substances 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
Abstract
Description
本發明係關於一種包膜用組合物,更詳細而言,係關於一種可用作固形製劑之包衣劑的包膜用組合物。The present invention relates to a coating composition, and more particularly to a coating composition which can be used as a coating agent for a solid preparation.
包膜或糖衣係被包裹於片劑上,以提高原料藥對光或濕度之穩定性,或者防止苦味、臭味、刺激等,或者防止晶鬚之產生,或者提高作為產品之美觀等。然而,就作為商品之美觀、尤其是表面之光澤或潤澤而言,先前之包膜劣於糖衣。另一方面,雖然包裹上糖衣之片劑的表面具有較高之光澤性,但由於糖衣步驟需要很長時間,故不僅製造成本上升,而且製劑由於糖衣而變得又大又重,由此攜帶性差,進而,糖衣步驟中高溫多濕之狀態持續較長時間,故有時亦會影響活性成分之穩定性。The envelope or the sugar coating is wrapped on the tablet to improve the stability of the drug substance to light or humidity, or to prevent bitterness, odor, irritation, etc., or to prevent the generation of whiskers, or to improve the appearance as a product. However, in terms of the aesthetics of the product, especially the gloss or moisturization of the surface, the previous envelope is inferior to the sugar coating. On the other hand, although the surface of the tablet coated with the sugar coating has a high gloss, since the sugar coating step takes a long time, not only the manufacturing cost rises, but also the preparation becomes large and heavy due to the sugar coating, thereby carrying Poorness, and further, the state of high temperature and high humidity in the sugar coating step lasts for a long period of time, and thus sometimes affects the stability of the active ingredient.
因此,一直嘗試對包膜片之表面賦予如糖衣片般之高光澤性。例如已提出:利用甜味成分與上光蠟之混合物進行上光之膜片(專利文獻1);使用阿拉伯膠之乾粉組合物(專利文獻2);調配有羥丙基纖維素及羧甲纖維素鈉之包膜組合物(專利文獻3)等。然而,由該等組合物所獲得之光澤尚不充分。Therefore, attempts have been made to impart a high gloss such as a sugar-coated sheet to the surface of the coated sheet. For example, a film for glazing using a mixture of a sweet component and a glazing wax has been proposed (Patent Document 1); a dry powder composition using gum arabic (Patent Document 2); and hydroxypropylcellulose and carboxymethylcellulose are formulated. A coating composition of sodium sodium (Patent Document 3) or the like. However, the gloss obtained from such compositions is not sufficient.
[專利文獻1]日本專利特開2001-89361號公報[專利文獻2]國際公開第2002/019987號小冊子[專利文獻3]日本專利特表2002-534373號公報[Patent Document 1] Japanese Laid-Open Patent Publication No. 2001-89361 (Patent Document 2) International Publication No. 2002/019987 pamphlet [Patent Document 3] Japanese Patent Laid-Open Publication No. 2002-534373
本發明之目的在於提供一種包膜製劑,其即使未包裹上糖衣亦具有高光澤性之表面。It is an object of the present invention to provide a coated preparation which has a high gloss surface even without being coated with a sugar coating.
本發明者等人為了實現上述目的而進行了潛心研究,結果意外發現,藉由使用分別以特定之比率調配有先前被用作固形製劑之包衣劑成分的羥丙基甲纖維素、聚乙二醇及滑石而成的組合物,可對製劑表面賦予較高之光澤性,從而完成了本發明。The inventors of the present invention conducted intensive studies in order to achieve the above object, and as a result, unexpectedly found that hydroxypropylmethylcellulose, polyethylene, which was previously formulated as a coating agent component previously used as a solid preparation, was used in a specific ratio. The composition of the diol and talc imparts a high gloss to the surface of the preparation, thereby completing the present invention.
即,本發明提供一種包膜用組合物,其特徵在於:含有(A)羥丙基甲纖維素、(B)聚乙二醇及(C)滑石,成分(A)與(B)之質量比(A:B)為1:0.22~1.25,且成分(A)與(C)之質量比(A:C)為1:0.8~3.8。That is, the present invention provides a composition for a coating comprising: (A) hydroxypropylmethylcellulose, (B) polyethylene glycol, and (C) talc, the mass of components (A) and (B) The ratio (A:B) is 1:0.22 to 1.25, and the mass ratio (A:C) of the components (A) to (C) is 1:0.8 to 3.8.
又,本發明提供一種包膜製劑,其係利用上述組合物包裹有厚度為20 μm~200 μm之包膜者。Further, the present invention provides a coating preparation which is coated with an envelope having a thickness of from 20 μm to 200 μm by the above composition.
若使用本發明之包膜用組合物對片劑進行包衣,則可形成具有漂亮光澤之膜,可獲得美麗外觀品質提高之包膜製劑。又,根據本發明,由於不需要糖衣步驟,故不僅可實現片劑之輕量化或小型化,而且可減低製造成本,進而,亦容易控制最終製劑之水分,故可維持活性成分之穩定性,並且亦可防止製劑產生變色。When the tablet is coated with the composition for a coating of the present invention, a film having a beautiful gloss can be formed, and a coating preparation having improved appearance quality can be obtained. Moreover, according to the present invention, since the sugar coating step is not required, not only the weight and size of the tablet can be reduced, but also the manufacturing cost can be reduced, and further, the moisture of the final preparation can be easily controlled, so that the stability of the active ingredient can be maintained. It also prevents discoloration of the formulation.
本發明之包膜用組合物,含有(A)羥丙基甲纖維素、(B) 聚乙二醇及(C)滑石。The coating composition of the present invention contains (A) hydroxypropylmethylcellulose, (B) Polyethylene glycol and (C) talc.
作為此處使用之成分(A)羥丙基甲纖維素,並無特別限定,但就賦予高光澤性之觀點而言,較好的是甲氧基之取代度為16.5~30.0,尤其好的是28.0~30.0,且羥丙氧基之取代度為4.0~32.0,尤其好的是7.0~12.0。又,羥丙基甲纖維素之黏度為,以20℃下之2%水溶液之黏度計,較好的是3~10,000 mPa·s,尤其好的是3~15 mPa.s。The component (A) hydroxypropylmethylcellulose used herein is not particularly limited, but from the viewpoint of imparting high gloss, it is preferred that the degree of substitution of the methoxy group is from 16.5 to 30.0, which is particularly preferable. It is 28.0~30.0, and the degree of substitution of hydroxypropoxy is 4.0~32.0, especially 7.0~12.0. Further, the viscosity of the hydroxypropylmethylcellulose is preferably from 3 to 10,000 mPa·s, particularly preferably from 3 to 15 mPa, based on the viscosity of a 2% aqueous solution at 20 ° C. s.
作為羥丙基甲纖維素之市售品,可舉出羥丙基甲纖維素2208、羥丙基甲纖維素2906、羥丙基甲纖維素2910等,該等可單獨使用,亦可併用2種以上。Examples of commercially available hydroxypropylmethylcellulose include hydroxypropylmethylcellulose 2208, hydroxypropylmethylcellulose 2906, and hydroxypropylmethylcellulose 2910. These may be used alone or in combination of two. More than one species.
相對於本發明之包膜用組合物之固形物含量總量,組合物中之羥丙基甲纖維素之含量就衣膜強度、包衣時之附著率及高光澤性之觀點而言,較好的是5~80質量%,尤其好的是10~60質量%,更好的是15~35質量%。The content of hydroxypropylmethylcellulose in the composition relative to the total solid content of the coating composition of the present invention is in terms of film strength, adhesion at the time of coating, and high gloss. The good is 5 to 80% by mass, particularly preferably 10 to 60% by mass, more preferably 15 to 35% by mass.
作為本發明中所使用之成分(B)聚乙二醇,並無特別限定,較好的是於25℃下為固體,其重量平均分子量較好的是190~42,000,尤其好的是7,300~9,300。再者,聚乙二醇之重量平均分子量係藉由GPC測定之聚苯乙烯換算之值。The polyethylene glycol which is the component (B) used in the present invention is not particularly limited, but is preferably a solid at 25 ° C, and preferably has a weight average molecular weight of 190 to 42,000, particularly preferably 7,300. 9,300. Further, the weight average molecular weight of the polyethylene glycol is a value in terms of polystyrene measured by GPC.
作為聚乙二醇之市售品,可舉出聚乙二醇200、聚乙二醇400、聚乙二醇600、聚乙二醇1000、聚乙二醇1500、聚乙二醇1540、聚乙二醇4000、聚乙二醇6000、聚乙二醇20000、聚乙二醇35000等,該等可單獨使用,亦可併用2種以上。Commercial products of polyethylene glycol include polyethylene glycol 200, polyethylene glycol 400, polyethylene glycol 600, polyethylene glycol 1000, polyethylene glycol 1500, polyethylene glycol 1540, and polycondensation. Ethylene glycol 4000, polyethylene glycol 6000, polyethylene glycol 20000, polyethylene glycol 35000, etc. These may be used individually or in combination of 2 or more types.
相對於1質量份之羥丙基甲纖維素,本發明之包膜用組 合物中之聚乙二醇之含量為為0.22~1.25質量份,較好的是0.25~1.0質量份,尤其好的是0.4~0.8質量份。若聚乙二醇之含量較少,則光澤性差,另一方面,若大量調配聚乙二醇,則包衣時之附著率下降,並且表面之平滑性易於消失。The envelope group of the present invention is used with respect to 1 part by mass of hydroxypropylmethylcellulose The content of the polyethylene glycol in the compound is from 0.22 to 1.25 parts by mass, preferably from 0.25 to 1.0 part by mass, particularly preferably from 0.4 to 0.8 part by mass. When the content of the polyethylene glycol is small, the gloss is poor. On the other hand, when a large amount of polyethylene glycol is blended, the adhesion rate at the time of coating is lowered, and the smoothness of the surface is liable to disappear.
本發明中所使用之成分(C)滑石之平均粒徑(依據JIS M8016之測定法),就賦予高光澤性之觀點而言,較好的是0.1~20 μm,尤其好的是1~12 μm,更好的是2~7 μm。若滑石之粒徑過大,則表面粗糙,難以獲得充分之光澤。又,對於滑石之粒度而言,較好的是粒徑超過75 μm者(無法通過網眼為75 μm之篩者)為0.2質量%以下,尤其好的是粒徑超過45 μm者(無法通過網眼為45 μm之篩者)為0.3質量%以下。The average particle diameter of the component (C) talc used in the present invention (measured according to JIS M8016) is preferably from 0.1 to 20 μm, particularly preferably from 1 to 12, from the viewpoint of imparting high gloss. Μm, more preferably 2~7 μm. If the particle size of the talc is too large, the surface is rough and it is difficult to obtain sufficient gloss. Further, as for the particle size of the talc, it is preferable that the particle size exceeds 75 μm (the sieve which cannot pass through the mesh of 75 μm) is 0.2% by mass or less, and particularly preferably the particle size exceeds 45 μm (cannot pass The mesh having a mesh size of 45 μm is 0.3% by mass or less.
又,於本發明中,為獲得較高之光澤,滑石之白度較為重要。較好的是使用滑石之白度(依據JIS M8016之測定法)為90以上者,尤其好的是使用白度為93以上者。若白度小,則難以表現出閃耀之光澤性。Further, in the present invention, in order to obtain a high gloss, the whiteness of talc is important. It is preferred that the whiteness of the talc (measured according to JIS M8016) is 90 or more, and it is particularly preferable to use a whiteness of 93 or more. If the whiteness is small, it is difficult to express the luster of the sparkle.
相對於1質量份之羥丙基甲纖維素,本發明之包膜用組合物中之滑石之含量為0.8~3.8質量份,較好的是1.2~3.8質量份,尤其好的是1.6~2.4質量份。若滑石之含量較少,則難以表現出閃耀之光澤性,另一方面,若大量調配滑石,則衣膜會變脆弱,並且包衣裝置內會產生灰塵,甚至灰塵會附著於片劑之表面。The content of the talc in the coating composition of the present invention is from 0.8 to 3.8 parts by mass, preferably from 1.2 to 3.8 parts by mass, particularly preferably from 1.6 to 2.4, based on 1 part by mass of the hydroxypropylmethylcellulose. Parts by mass. If the content of talc is small, it is difficult to express the luster of glare. On the other hand, if a large amount of talc is blended, the coating film becomes weak, and dust is generated in the coating device, and even dust adheres to the surface of the tablet. .
於本發明之包膜用組合物中,較好的是除了上述成分以 外進一步調配著色劑。作為著色劑,可舉出兒茶單寧粉、薑黃萃取液、黃色三氧化二鐵、Opaspray K-1-24904、橘子香精、褐色氧化鐵、碳黑、焦糖、洋紅、胡蘿蔔素液、β-胡蘿蔔素、甘草萃取物、金箔、黑氧化鐵、輕質無水矽酸、氧化鈦、三氧化二鐵、食用藍色1號、食用黃色4號、食用黃色4號鋁色澱、食用黃色5號、食用紅色2號、食用紅色3號、食用紅色102號、氫氧化鈉、葉綠素銅鈉、葉綠素銅、裸麥綠葉萃取物、d-龍腦、肉豆蔻酸辛基十二烷酯、藥用碳、核黃素丁酸酯、核黃素、綠茶粉、核黃素磷酸鈉、玫瑰油等,該等可單獨使用,或者混合使用二種以上。In the composition for a coating of the present invention, it is preferred to The colorant is further formulated externally. Examples of the coloring agent include catechin tannin powder, turmeric extract, yellow ferric oxide, Opaspray K-1-24904, orange flavor, brown iron oxide, carbon black, caramel, magenta, carotenoid solution, and β. Carotene, licorice extract, gold foil, black iron oxide, light anhydrous citric acid, titanium oxide, ferric oxide, edible blue No. 1, edible yellow No. 4, edible yellow No. 4 aluminum lake, edible yellow 5 No., edible red No. 2, edible red No. 3, edible red No. 102, sodium hydroxide, copper chlorophyll sodium, chlorophyll copper, rye green leaf extract, d-borneol, octyl dodecyl myristate, medicinal Carbon, riboflavin butyrate, riboflavin, green tea powder, riboflavin sodium phosphate, rose oil, etc., may be used singly or in combination of two or more.
相對於1份之羥丙基甲纖維素,組合物中之著色劑之含量以質量比計較好的是5份以下,尤其好的是2份以下,更好的是1份以下。The content of the coloring agent in the composition is preferably 5 parts or less, particularly preferably 2 parts or less, more preferably 1 part or less, based on 1 part by weight of hydroxypropylmethylcellulose.
於本發明之包膜用組合物中,除上述成分以外,視需要可添加通常口服醫藥品之包膜中所使用之醫藥品添加物,例如增塑劑、包衣劑、分散劑、消泡劑等。In the coating composition of the present invention, in addition to the above components, a pharmaceutical additive such as a plasticizer, a coating agent, a dispersing agent, or a defoaming agent used in a coating of a general oral pharmaceutical product may be added as needed. Agents, etc.
作為增塑劑之具體例,可舉出:karion83、檸檬酸三乙酯、甘油、脂肪酸甘油酯、芝麻油、二甲基聚矽氧烷·二氧化矽混合物、D-山梨糖醇、中長鏈三酸甘油酯、源自玉米澱粉之糖醇液、甘油三乙酸酯、濃甘油、蓖麻油、鄰苯二甲酸二乙酯、鄰苯二甲酸二丁酯、丁基鄰苯二甲醯基乙醇酸丁酯、聚氧乙烯(105)聚氧丙烯(5)二醇、丙二醇、聚山梨酸酯80、棉籽油.大豆油混合物、單硬脂酸甘油酯 等,該等可單獨使用,或混合使用二種以上。於添加增塑劑之情形時,組合物中之含量較好的是40質量%以下。Specific examples of the plasticizer include karion 83, triethyl citrate, glycerin, fatty acid glyceride, sesame oil, dimethyl polyoxyalkylene cerium oxide mixture, D-sorbitol, and medium long chain. Triglyceride, sugar alcohol liquid derived from corn starch, triacetin, concentrated glycerin, castor oil, diethyl phthalate, dibutyl phthalate, butyl phthalate Butyl glycolate, polyoxyethylene (105) polyoxypropylene (5) diol, propylene glycol, polysorbate 80, cottonseed oil. Soybean oil mixture, glyceryl monostearate Etc., these may be used singly or in combination of two or more. In the case where a plasticizer is added, the content in the composition is preferably 40% by mass or less.
作為包衣劑之具體例,可舉出:丙烯酸乙酯·甲基丙烯酸甲酯共聚物分散液、乙醯甘油脂肪酸酯、甲基丙烯酸胺烷基酯共聚物E、甲基丙烯酸胺烷基酯共聚物RS、阿拉伯膠、阿拉伯膠粉、乙基纖維素、乙基纖維素水分散液、辛基癸基三酸甘油脂、Opadry AMB、Opadry OY-6950、Opadry OY-S-7135、Opadry OY-S-8471、Opadry OY-S-9607、Opadry OY-S-22829、Opadry OY-S-22835、Opadry OY-S-22961、橄欖油、高嶺土、可可脂、夏枯草、蓖麻蠟、焦糖、巴西棕櫚蠟、羧乙烯聚合物、羧甲基乙基纖維素、羧甲基澱粉鈉、羧甲纖維素鈣、羧甲纖維素鈉、水合二氧化矽、乾燥氫氧化鋁凝膠、乾燥乳狀白蟲膠、乾燥甲基丙烯酸共聚物LD、寒梅粉、魚鱗箔、金箔、銀箔、檸檬酸三乙酯、甘油、脂肪酸甘油酯、矽酸鎂、輕質無水矽酸、含輕質無水矽酸之羥丙基纖維素、稀性液體石蠟、鯨蠟、結晶纖維素、硬化油、合成矽酸鋁、合成蠟、高葡萄糖水飴、硬蠟、琥珀醯明膠、小麥粉、小麥澱粉、米澱粉、醋酸纖維素、乙酸乙烯酯樹脂、鄰苯二甲酸醋酸纖維素、白色蜂蠟、氧化鈦、氧化鎂、甲基丙烯酸二甲基胺基乙酯·甲基丙烯酸甲酯共聚物、二甲基聚矽氧烷(內服用)、二甲基聚矽氧烷·二氧化矽混合物、燒石膏、蔗糖脂肪酸酯、沉香粉、氫氧化鋁凝膠、氫化松香甘油酯、硬脂醇、硬脂酸、硬脂酸鋁、硬脂酸鈣、硬脂酸聚烴氧酯40、硬脂 酸鎂、精製明膠、精製蟲膠、精製白糖、玉米蛋白、倍半異硬脂酸山梨糖醇酐、鯨蠟醇、石膏、明膠、蟲膠、山梨糖醇酐脂肪酸酯、D-山梨糖醇、D-山梨糖醇液、磷酸三鈣、碳酸鈣、碳酸鎂、單糖漿、中金箔、沈澱碳酸鈣、低取代羥丙基纖維素、萜烯樹脂、澱粉(溶性)、玉米糖漿、玉米油、甘油三乙酸酯、乳酸鈣、乳糖、濃甘油、白色蟲膠、白糖、蜂蜜、石蠟、珍珠粉、馬鈴薯澱粉、羥丙基纖維素、羥丙基甲纖維素鄰苯二甲酸酯、胡椒基丁醚、蓖麻油、鄰苯二甲酸二乙酯、鄰苯二甲酸二丁酯、丁基鄰苯二甲醯基乙醇酸丁酯、葡萄糖、反丁烯二酸.硬脂酸·聚乙烯醇縮醛二乙胺基乙酸酯.羥丙基甲纖維素2910混合物、聚三葡萄糖、丙二醇、膨潤土、聚維酮、聚氧乙烯硬化蓖麻油40、聚氧乙烯硬化蓖麻油60、聚氧乙烯(105)聚氧丙烯(5)二醇、聚氧乙烯(160)聚氧丙烯(30)二醇、聚山梨酸酯80、聚乙烯醇縮醛二乙胺基乙酸酯、D-甘露糖醇、水飴、蜂蠟、肉豆蔻醇、無水矽酸水合物、鄰苯二甲酸酐、無水磷酸氫鈣、甲基丙烯酸共聚物L、甲基丙烯酸共聚物LD、甲基丙烯酸共聚物S、偏矽酸鋁酸鎂、甲纖維素、丙烯酸2-甲基-5-乙烯基吡啶基甲酯.甲基丙烯酸共聚物、漆樹蠟、單硬脂酸鋁、單硬脂酸甘油酯、山梨糖醇酐單月桂酸酯、褐煤酸酯蠟、藥用碳、聚桂醇、硫酸鈣、液體石蠟、DL-蘋果酸、正磷酸氫鈣、磷酸氫鈣、磷酸氫鈉、磷酸二氫鈣、松香等,該等可單獨使用,或混合使用二種以上。於添加包衣劑之情形時,組合物中之含量較好的是40質量 %以下。Specific examples of the coating agent include ethyl acrylate/methyl methacrylate copolymer dispersion, acetamidine glycerin fatty acid ester, aminoalkyl methacrylate copolymer E, and aminoalkyl methacrylate. Ester copolymer RS, gum arabic, gum arabic powder, ethyl cellulose, ethyl cellulose aqueous dispersion, octyl decyl triglyceride, Opadry AMB, Opadry OY-6950, Opadry OY-S-7135, Opadry OY-S-8471, Opadry OY-S-9607, Opadry OY-S-22829, Opadry OY-S-22835, Opadry OY-S-22961, olive oil, kaolin, cocoa butter, Prunella vulgaris, ramie wax, coke Sugar, carnauba wax, carboxyvinyl polymer, carboxymethyl ethyl cellulose, sodium carboxymethyl starch, calcium carboxymethyl cellulose, sodium carboxymethyl cellulose, hydrated cerium oxide, dried aluminum hydroxide gel, dried Milky white shellac, dry methacrylic acid copolymer LD, cold plum powder, fish scale foil, gold foil, silver foil, triethyl citrate, glycerin, fatty acid glyceride, magnesium citrate, light anhydrous citric acid, light and anhydrous Hydroxypropyl cellulose of citric acid, dilute liquid paraffin, cetyl wax, Crystal cellulose, hardened oil, synthetic aluminum silicate, synthetic wax, high glucose leeches, hard wax, amber gelatin, wheat flour, wheat starch, rice starch, cellulose acetate, vinyl acetate resin, phthalic acid acetate , white beeswax, titanium oxide, magnesium oxide, dimethylaminoethyl methacrylate·methyl methacrylate copolymer, dimethyl polyoxyalkylene (administered internally), dimethyl polyoxane Ceria mixture, calcined gypsum, sucrose fatty acid ester, agarwood powder, aluminum hydroxide gel, hydrogenated rosin glyceride, stearyl alcohol, stearic acid, aluminum stearate, calcium stearate, stearic acid polyhydrocarbon Oxygen ester 40, hard fat Magnesium sulphate, refined gelatin, refined shellac, refined white sugar, zein, sesquisulphate sorbitan, cetyl alcohol, gypsum, gelatin, shellac, sorbitan fatty acid ester, D-sorbose Alcohol, D-sorbitol liquid, tricalcium phosphate, calcium carbonate, magnesium carbonate, monosaccharide syrup, medium gold foil, precipitated calcium carbonate, low-substituted hydroxypropyl cellulose, terpene resin, starch (soluble), corn syrup, corn Oil, triacetin, calcium lactate, lactose, concentrated glycerin, white shellac, white sugar, honey, paraffin, pearl powder, potato starch, hydroxypropyl cellulose, hydroxypropyl methyl cellulose phthalate , piperonyl butoxide, castor oil, diethyl phthalate, dibutyl phthalate, butyl phthalate, butyl phthalate, glucose, fumaric acid. Stearic acid·polyvinyl acetal diethylamine acetate. Hydroxypropyl methylcellulose 2910 mixture, polytriglucose, propylene glycol, bentonite, povidone, polyoxyethylene hardened castor oil 40, polyoxyethylene hardened castor oil 60, polyoxyethylene (105) polyoxypropylene (5) two Alcohol, polyoxyethylene (160) polyoxypropylene (30) diol, polysorbate 80, polyvinyl acetal diethylamine acetate, D-mannitol, leeches, beeswax, myristyl alcohol, Anhydrous citric acid hydrate, phthalic anhydride, anhydrous calcium hydrogen phosphate, methacrylic acid copolymer L, methacrylic acid copolymer LD, methacrylic acid copolymer S, magnesium metasilicate aluminate, methyl cellulose, acrylic acid 2-methyl-5-vinylpyridylmethyl ester. Methacrylic acid copolymer, lacquer wax, aluminum monostearate, glyceryl monostearate, sorbitan monolaurate, montan acid ester wax, medicinal carbon, polyglycerol, calcium sulfate, liquid paraffin, DL-malic acid, calcium hydrogen orthophosphate, calcium hydrogen phosphate, sodium hydrogen phosphate, calcium dihydrogen phosphate, rosin, etc., may be used alone or in combination of two or more. In the case of adding a coating agent, the content in the composition is preferably 40 mass. %the following.
作為分散劑之具體例,可舉出:甲基丙烯酸胺烷基酯共聚物RS、阿拉伯膠、阿拉伯膠粉、褐藻酸丙二醇酯、乙醇、油酸、羧乙烯聚合物、羧甲纖維素鈉、瓊脂粉、檸檬酸、檸檬酸鈉、甘油、脂肪酸甘油酯、矽酸鎂、輕質無水矽酸、結晶纖維素、硬化油、合成矽酸鋁、磷酸膽鹼、紅花子油、白色蜂蠟、氧化鈦、磺琥珀酸鈉二辛酯、蔗糖脂肪酸酯、氫氧化鈉、硬脂酸、硬脂酸鎂、精製油酸、精製大豆卵磷脂、倍半異硬脂酸山梨糖醇酐、山梨糖醇酐脂肪酸酯、D-山梨糖醇、大豆油、大豆卵磷脂、低取代羥丙基纖維素、糊精、玉米澱粉、黃芪膠粉、山梨糖醇酐三油酸酯、乳糖、濃甘油、馬鈴薯澱粉、羥乙基纖維素、羥丙基澱粉、羥丙基纖維素、丙二醇、丙二醇脂肪酸酯、膨潤土、聚維酮、聚氧乙烯硬化蓖麻油、聚氧乙烯硬化蓖麻油40、聚氧乙烯硬化蓖麻油60、聚氧乙烯(105)聚氧丙烯(5)二醇、聚氧乙烯(160)聚氧丙烯(30)二醇、聚山梨酸酯20、聚山梨酸酯60、聚山梨酸酯80、聚磷酸鈉、無水檸檬酸鈉、無水焦磷酸鈉、偏矽酸鋁酸鎂、偏磷酸鈉、甲纖維素、漆樹蠟、山梨糖醇酐單油酸酯、單硬脂酸鋁、單硬脂酸甘油酯、山梨糖醇酐單棕櫚酸酯、山梨糖醇酐單月桂酸酯、十二烷基硫酸鈉、聚桂醇、液體石蠟、磷酸氫鈣等,該等可單獨使用,或混合使用二種以上。於添加分散劑之情形時,組合物中之含量較好的是25質量%以下。Specific examples of the dispersing agent include aminoalkyl methacrylate copolymer RS, gum arabic, gum arabic powder, propylene glycol alginate, ethanol, oleic acid, carboxyvinyl polymer, sodium carboxymethylcellulose, Agar powder, citric acid, sodium citrate, glycerin, fatty acid glyceride, magnesium citrate, light anhydrous citric acid, crystalline cellulose, hardened oil, synthetic aluminum citrate, phosphoric acid choline, safflower oil, white beeswax, oxidation Titanium, sodium sulfosuccinate dioctyl ester, sucrose fatty acid ester, sodium hydroxide, stearic acid, magnesium stearate, refined oleic acid, refined soy lecithin, sesquistea sulphate, sorbose Alcohol fatty acid ester, D-sorbitol, soybean oil, soy lecithin, low-substituted hydroxypropyl cellulose, dextrin, corn starch, gum tragacanth powder, sorbitan trioleate, lactose, concentrated glycerin , potato starch, hydroxyethyl cellulose, hydroxypropyl starch, hydroxypropyl cellulose, propylene glycol, propylene glycol fatty acid ester, bentonite, povidone, polyoxyethylene hardened castor oil, polyoxyethylene hardened castor oil 40, poly Oxyethylene hardened castor oil 60 , polyoxyethylene (105) polyoxypropylene (5) diol, polyoxyethylene (160) polyoxypropylene (30) diol, polysorbate 20, polysorbate 60, polysorbate 80, poly Sodium phosphate, anhydrous sodium citrate, anhydrous sodium pyrophosphate, magnesium metasilicate aluminate, sodium metaphosphate, methylcellulose, lacquer wax, sorbitan monooleate, aluminum monostearate, monostearic acid Glyceryl ester, sorbitan monopalmitate, sorbitan monolaurate, sodium lauryl sulfate, polyglycerol, liquid paraffin, calcium hydrogen phosphate, etc., which may be used alone or in combination. More than one species. In the case where a dispersing agent is added, the content in the composition is preferably 25% by mass or less.
作為消泡劑之具體例,可舉出:乙醇、脂肪酸甘油酯、 二甲基聚矽氧烷(內服用)、二甲基聚矽氧烷·二氧化矽混合物、蔗糖脂肪酸酯、矽樹脂乳液、矽消泡劑、硬脂酸聚烴氧酯40、山梨糖醇酐脂肪酸酯、山梨糖醇酐三油酸酯、聚山梨酸酯80等,該等可單獨添加,或混合添加二種以上。於添加消泡劑之情形時,組合物中之含量較好的是10質量%以下。Specific examples of the antifoaming agent include ethanol and fatty acid glycerides. Dimethylpolyoxane (internal administration), dimethyl polyoxane·cerium oxide mixture, sucrose fatty acid ester, oxime resin emulsion, bismuth defoamer, polyoxyl stearate 40, sorbose The alcoholic anhydride fatty acid ester, the sorbitan trioleate, the polysorbate 80, etc. may be added individually or in mixture of two or more types. In the case where an antifoaming agent is added, the content in the composition is preferably 10% by mass or less.
本發明之包膜製劑藉由如下方式而製造:製備將含有羥丙基甲纖維素、聚乙二醇及滑石之包膜用組合物溶解.懸浮而成之包衣液,並噴霧包覆於固形製劑之最外側表面。作為固形製劑之劑形,較好的是片劑。The coating preparation of the present invention is produced by dissolving a composition for a coating containing hydroxypropylmethylcellulose, polyethylene glycol and talc. The coating liquid is suspended and spray coated on the outermost surface of the solid preparation. As a dosage form of the solid preparation, a tablet is preferred.
於固形製劑中,可適宜調配各種藥效成分,例如可舉出:抗壞血酸、抗壞血酸鈣、抗壞血酸鈉等維生素C類;泛酸鈣、硝酸硫胺、鹽酸硫胺、硝酸二硫胺、二硫硫胺、二鯨蠟基硫酸硫胺明、鹽酸呋喃硫胺、鹽酸基世甲命、奧托硫胺、賽可硫胺、雙異丁硫胺、雙苯醯硫胺、苯磷硫胺、核黃素、核黃素丁酸酯、核黃素磷酸鈉、鹽酸吡哆醇、磷酸吡哆醛、氰鈷胺、鹽酸羥基鈷銨、酯酸羥基鈷銨、甲鈷胺、煙鹼酸、菸鹼醯胺、生物素、葉酸等維生素B類;γ一穀維素等自主神經調節劑;硫辛醯胺、乳清酸等類維生素效應物質;磷酸氫鈣、乳酸鈣等礦物質;乙酸d-α-生育醇酯、乙酸dl-α-生育醇酯、琥珀酸d-α-生育醇酯、琥珀酸dl-α-生育醇酯鈣等維生素E;麥角鈣化醇、膽鈣化醇等維生素D;L-半胱胺酸、甲硫胺酸、甘胺酸、鹽酸精胺酸等胺基酸;胺基乙基磺酸、葡糖醛醯胺、葡糖醛酸內 酯、甘草酸、熊去氧膽酸等肝臟損傷用藥;何首烏萃取物、歐洲山楂萃取物、刺五加乾燥萃取物、淫羊藿萃取物、薏仁萃取物、肝臟水解物、膽汁萃取物粉、柴胡乾燥萃取物、川穹乾燥萃取物、山裹紅乾燥萃取物、茯苓乾燥萃取物等天然藥萃取物等。In the solid preparation, various medicinal ingredients can be suitably formulated, and examples thereof include vitamin C such as ascorbic acid, calcium ascorbate, and sodium ascorbate; calcium pantothenate, thiamine nitrate, thiamine hydrochloride, dithiamine nitrate, and dithiothiamine. , cetyl sulphate sulphate sulphate, sulphate sulphate hydrochloride, hydrazine hydrazine, olto thiamine, seleton sulphate, bis-isobutyl sulphate, bis-benzopyramine, phenylphosphine sulphate, nuclear yellow , riboflavin butyrate, riboflavin sodium phosphate, pyridoxine hydrochloride, pyridoxal phosphate, cyanocobalamin, hydroxycobaltium hydrochloride, hydroxycobalt ammonium sulphate, methylcobalamin, nicotinic acid, nicotinamide , biotin, folic acid and other vitamin B; γ-oryzanol and other autonomic nervous regulators; sulphuric acid, whey acid and other vitamin-like substances; calcium hydrogen phosphate, calcium lactate and other minerals; acetic acid d-α- Vitamin E such as tocopherol ester, dl-α-tocopheryl acetate, d-α-tocopheryl succinate, dl-α-tocopheryl succinate, vitamin D such as ergocalciferol and cholecalciferol; - amino acid such as cysteine, methionine, glycine, arginine hydrochloride; amine B Acid, glucuronic Amides, the glucuronic acid Herbal acid such as ester, glycyrrhizic acid, and ursodeoxycholic acid; Polygonum multiflorum extract, European hawthorn extract, Acanthopanax senticosus extract, Epimedium extract, Coix seed extract, liver hydrolysate, bile extract powder, Natural extracts such as Bupleurum dry extract, dried extract of Chuanxiong, dried red extract of mountain, dried extract of medlar, and the like.
製造製劑之方法並無特別限定,於藥效成分中視需要添加製劑添加物,並利用先前以來之常法製造即可。例如,利用通常採用之普通的製劑化方法(津田恭介.上野壽著、「醫藥開發基礎講座X I藥劑製造法(上)、(下)」、地人書館、1971年發行;伸井由宣著、「製劑工學手冊」、地人書館、1983年發行;仲井由宣著、「最新粉體之材料設計」、Techno System、1988年發行;荒川正文著、「醫藥之開發Ⅱ製劑之單元操作及機械」、廣川書店、1989年發行;橋田充著、「口服製劑之設計及評價」、藥業時報公司、1995年發行;橋田充著、「口服製劑之處方設計」、藥業時報公司、1995年發行)來製備即可。又,於必須製備造粒粉末之情形時,可藉由如下方式而製備:將採用通常利用之造粒法(使用含有水或有機溶劑之溶液或分散液的噴霧造粒法、攪拌造粒法、流化造粒法、旋轉造粒法、旋轉流化造粒法等濕式造粒法,使用粉粒狀之黏合劑的壓密造粒法等乾式造粒法等)製造之原粉末.粉末劑.細粒劑.顆粒劑等與製劑添加物混合,並進行壓縮成型。進而,亦可對由本發明之包膜用組合物所得之膜層的下側進行底層包衣,而製成具有二層或三層等多層膜層之包膜製劑。The method of producing the preparation is not particularly limited, and a preparation additive may be added to the medicinal ingredient as needed, and it may be produced by a conventional method. For example, the general formulation method that is usually used (Tsujin Kousuke. Ueno Shou, "Medical Development Basic Lecture XI Pharmaceutical Manufacturing Law (I), (below)", "People's Library", issued in 1971; , "Manufacturing Engineering Handbook", and the People's Library, issued in 1983; Nakai Yusuke, "The Latest Powder Material Design", Techno System, issued in 1988; Arakawa Text, "Pharmaceutical Development II Preparation Unit Operation & Machinery", Hirokawa Bookstore, issued in 1989; Hiroshi Hiroshi, "Design and Evaluation of Oral Formulations", Pharmaceutical Times, 1995, Hiroshi Hiroshi, "Design of Oral Formulations", Pharmaceutical Times, Released in 1995). Further, when it is necessary to prepare a granulated powder, it can be prepared by a granulation method which is generally used (a spray granulation method using a solution or dispersion containing water or an organic solvent, stirring granulation method) And the original powder produced by a fluid granulation method, a rotary granulation method, a rotary granulation method or the like, a wet granulation method, a dry granulation method such as a compact granulation method using a powdery binder, and the like. Powder. Fine granules. The granules and the like are mixed with the formulation additive and compression molded. Further, the underside of the film layer obtained from the coating composition of the present invention may be subjected to a primer coating to prepare a coating film having a multilayer film layer of two or three layers.
作為製劑化時使用之製劑添加劑,可舉出藥學上許可之載體,例如穩定(化)劑、界面活性劑、潤滑化劑、潤滑劑、溶解劑、緩衝劑、甜味劑、基質、吸附劑、調味劑、黏合劑、懸浮(化)劑、抗氧化劑、光澤劑、香料、包衣劑、濕潤劑、濕潤調節劑、填充劑、消泡劑、清涼劑、著香劑.香料、著色劑、等張劑、軟化劑、乳化劑、黏稠(化)劑、發泡劑、pH調節劑、賦形劑、分散劑、崩解劑、崩解助劑、芳香劑、防濕劑、防腐劑、保存劑、溶解劑、溶解助劑、溶劑、流動化劑等,作為該等製劑添加劑之具體例,例如可使用裝訂冊(日本醫藥添加劑協會、「醫藥添加物事典2005」、藥事日報社、2005年發行)中所揭示者。As the preparation additive used in the formulation, a pharmaceutically acceptable carrier such as a stabilizer, a surfactant, a lubricating agent, a lubricant, a solvent, a buffer, a sweetener, a matrix, and an adsorbent may be mentioned. , flavoring agents, adhesives, suspending (chemical) agents, antioxidants, brighteners, perfumes, coating agents, wetting agents, wetting regulators, fillers, defoamers, cooling agents, flavoring agents. Perfume, colorant, isotonic agent, softener, emulsifier, viscous agent, foaming agent, pH adjuster, excipient, dispersant, disintegrant, disintegration aid, fragrance, moisture proof As a specific example of the additives of the preparations, for example, a binding book (Japanese Pharmaceutical Additives Association, "Pharmaceutical Additives Code 2005", etc., may be used as a specific example of the additives of the preparations, such as a preservative, a preservative, a preservative, a dissolving agent, a dissolving agent, a solvent, a fluidizing agent, and the like. Revealed in the Pharmaceutical Daily, issued in 2005).
對以如上所述之方式而製造的裸片或包膜片等固形製劑上包上包膜用組合物之包衣方法,並無特別限定,例如可舉出鍋包衣法、流化層包衣法、旋轉包衣法、乾式包衣法、或者該等之組合方法等。含有本發明之包膜用組合物之塗層液,係於羥丙基甲纖維素、聚乙二醇及滑石中,進一步視需要添加醫藥添加物並稱量包膜用組合物,將該組合物溶解/懸浮於純化水或乙醇等低級醇或者其等之混合液中而製備。包衣液較好的是調整成固形物含量為通常1~50質量%,尤其好的是調整成2~30質量%,更好的是調整成5~20質量%。The coating method of the coating composition for a solid preparation such as a die or a coated sheet produced as described above is not particularly limited, and examples thereof include a pan coating method and a fluidized layer package. A clothing method, a spin coating method, a dry coating method, or a combination method of the above. The coating liquid containing the coating composition of the present invention is used in hydroxypropylmethylcellulose, polyethylene glycol, and talc, and further, if necessary, a pharmaceutical additive is added and the coating composition is weighed, and the combination is used. The product is prepared by dissolving/suspending in a purified alcohol or a lower alcohol such as ethanol or a mixture thereof. The coating liquid is preferably adjusted to have a solid content of usually 1 to 50% by mass, particularly preferably 2 to 30% by mass, more preferably 5 to 20% by mass.
於本發明中,製劑上形成之膜層之厚度,係根據製劑形狀或大小而有所不同,但就獲得具有美麗光澤之表面的觀點而言,較好的是20 μm~200 μm,尤其好的是30 μm~100 μm,更好的是40 μm~80 μm。例如,直徑為9 mm且質量200 mg左右之片劑,為了獲得上述膜層之厚度,較好的是大約以3~30 mg/片進行包衣,更好的是約以3~15 mg/片進行包衣,尤其好的是約以6~12 mg/片進行包衣。若膜層之厚度過薄,則無法獲得充分之光澤,另一方面,若膜層之厚度較大,則需要包衣所必需之時間。In the present invention, the thickness of the film layer formed on the preparation varies depending on the shape or size of the preparation, but from the viewpoint of obtaining a surface having a beautiful luster, it is preferably 20 μm to 200 μm, particularly preferably. Is 30 μm~100 Μm, more preferably 40 μm~80 μm. For example, a tablet having a diameter of 9 mm and a mass of about 200 mg, in order to obtain the thickness of the above-mentioned film layer, is preferably coated at about 3 to 30 mg/tablet, more preferably about 3 to 15 mg/ The tablets are coated, and it is especially preferred to coat them at about 6 to 12 mg per tablet. If the thickness of the film layer is too thin, sufficient gloss cannot be obtained. On the other hand, if the thickness of the film layer is large, the time necessary for coating is required.
本發明之製劑,亦可於由包膜用組合物所得之膜層下側進行底層包衣,而成為具有多個膜層之包膜製劑。The preparation of the present invention may be subjected to a primer coating on the lower side of the film layer obtained from the coating composition to form a coating preparation having a plurality of film layers.
例如,固形製劑中含有L-半胱胺酸類等發出令人不適之臭味的藥效成分之情形時,為了掩蓋該臭味,較好的是裹上包膜。包膜中,可適宜添加上述口服醫藥品之包膜中所使用之醫藥品添加物,尤其是就防臭效果之觀點而言,較好的是添加聚乙烯醇之部分皂化物。聚乙烯醇部分皂化物之皂化度,就令人不適之臭味的減低效果之觀點而言,較好的是70~97 mol%,尤其好的是78~96 mol%,又,平均聚合度較好的是200~3,300,尤其好的是300~1,500。此處,皂化度依據JIS K6726(聚乙烯醇試驗方法)而測定。又,包膜中之聚乙烯醇之含量,就防臭效果、被膜強度及包衣容易性之觀點而言,較好的是30~100質量%,尤其好的是40~95質量%。For example, when the solid preparation contains a medicinal ingredient such as L-cysteine which causes an unpleasant odor, it is preferred to coat the envelope in order to mask the odor. In the envelope, a pharmaceutical additive used in the coating of the above oral pharmaceutical product can be suitably added, and in particular, from the viewpoint of the deodorizing effect, it is preferred to add a partial saponified product of polyvinyl alcohol. The degree of saponification of the partially saponified polyvinyl alcohol is preferably from 70 to 97 mol%, particularly preferably from 78 to 96 mol%, and the average degree of polymerization, from the viewpoint of an unpleasant odor reduction effect. It is preferably 200 to 3,300, and particularly preferably 300 to 1,500. Here, the degree of saponification is measured in accordance with JIS K6726 (polyvinyl alcohol test method). Further, the content of the polyvinyl alcohol in the coating film is preferably from 30 to 100% by mass, particularly preferably from 40 to 95% by mass, from the viewpoint of the deodorizing effect, the film strength, and the ease of coating.
又,固形製劑中含有泛酸鈣、以及L-半胱胺酸類等具有分解泛酸鈣之作用而損害其穩定性之藥效成分之情形時,較好的是於固形製劑中調配泛酸鈣以外之活性成分,並於包覆該製劑之膜層中調配泛酸鈣。於該情形時,為了掩蓋 上述發出不快臭味之藥效成分而包裹上的包膜,亦可包裹於含有泛酸或其鹽之膜層的上側或下側、或者兩側。含泛酸鈣之膜層中,可適宜添加上述口服醫藥品之包膜所使用之醫藥添加物,尤其好的是添加水溶性或者胃溶性之膜基材,例如自甲纖維素、羥丙基纖維素、羥丙基甲纖維素、聚乙烯吡咯烷酮、羧乙烯聚合物、聚乙烯醇、甲基丙烯酸胺基烷基酯共聚物E、聚乙烯醇縮醛二乙胺基乙酸等中所選擇之1種或2種以上。Further, when the solid preparation contains calcium phytate and L-cysteine, and the like, which has a function of decomposing calcium pantothenate to impair the stability thereof, it is preferred to prepare an activity other than calcium pantothenate in the solid preparation. Ingredients, and calcium pantothenate is formulated in the film layer covering the formulation. In this case, in order to cover up The coating film wrapped with the medicinal ingredient which emits unpleasant odor may be wrapped on the upper side or the lower side or both sides of the film layer containing pantothenic acid or a salt thereof. In the film layer containing calcium pantothenate, a pharmaceutical additive used for the coating of the above oral pharmaceutical product may be suitably added, and it is particularly preferable to add a water-soluble or gastric-soluble film substrate such as self-methyl cellulose or hydroxypropyl fiber. Selected from hydroxypropylmethylcellulose, polyvinylpyrrolidone, carboxyvinyl polymer, polyvinyl alcohol, aminoalkyl methacrylate copolymer E, polyvinyl acetal diethylaminoacetic acid, etc. Kind or more than two.
因此,藉由包膜可提供具有美麗光澤之表面之製劑。Therefore, a formulation having a beautifully glossy surface can be provided by the envelope.
以下,列舉實施例就本發明加以具體說明,但本發明並不限定於該等實施例。Hereinafter, the present invention will be specifically described by way of examples, but the present invention is not limited to the examples.
使用960 g之L-半胱胺酸(協和醱酵製造)、1237.2 g之直接壓片用抗壞血酸(BASF日本製造)、147.6 g之泛酸鈣型S(BASF日本製造)、567.2 g之結晶纖維素(VIVAPUR12:RETTENMAIER製造)、200 g之結晶纖維素(Ceolus KG802:旭化成化學製造)、200 g之低取代羥丙基纖維素(LH-11:信越化學製造)、16 g之輕質無水矽酸(Adsolider 101:FREUND產業製造)、32 g之硬脂酸鎂(太平化學製造),製造壓片用混合粉,利用旋轉式壓片機(VIRGO-0512型壓片機:菊水製作所製造),以9 mmΦ之研缽棒進行壓片直至每1片質量達到210 mg為止,獲得裸片。其次,將36 g之羥丙基甲纖維素2910(TC-5RW:信越化學工業製造)、 21 g之聚乙二醇6000(日本油脂製造)、69 g之滑石(勝光山礦業所;平均粒徑為4.6 μm、粒度45 μm篩餘量為0.1%、白度為93.6%)、24 g之氧化鈦(石原產業製造),溶解.懸浮於純化水:日本藥典乙醇(3:1)混合液850 g中,獲得包膜液。繼而,將3000 g之裸片放入包衣機(Hi-Coater HCT-48、FREUND產業),進行包衣直至裸片每1片質量增加量達到10 mg為止,獲得每1片之質量為220 mg之包膜片(衣膜厚度為64.5 μm:n=10之平均、圖像解析法)。960 g of L-cysteine (manufactured by Kyowa Mastic), 1237.2 g of ascorbic acid for direct compression (BASF made in Japan), 147.6 g of calcium pantothenate type S (BASF made in Japan), and 567.2 g of crystalline cellulose (VIVAPUR12: manufactured by RETTENMAIER), 200 g of crystalline cellulose (Ceolus KG802: manufactured by Asahi Kasei Chemicals), 200 g of low-substituted hydroxypropylcellulose (LH-11: manufactured by Shin-Etsu Chemical Co., Ltd.), and 16 g of light-weight anhydrous citric acid (Adsolider 101: manufactured by FREUND), 32 g of magnesium stearate (manufactured by Taiping Chemical Co., Ltd.), and a mixed powder for tableting, which was produced by a rotary tableting machine (VIRGO-0512 tableting machine: manufactured by Kikusui Seisakusho Co., Ltd.) A 9 mm Φ mortar rod was pressed until each piece reached a mass of 210 mg, and a bare piece was obtained. Next, 36 g of hydroxypropylmethylcellulose 2910 (TC-5RW: manufactured by Shin-Etsu Chemical Co., Ltd.), 21 g of polyethylene glycol 6000 (made by Nippon Oil & Fats), 69 g of talc (Shengguangshan Mining Institute; average particle size of 4.6 μm, particle size 45 μm sieve margin 0.1%, whiteness 93.6%), 24 g Titanium oxide (made by Ishihara Industry), dissolved. Suspended in purified water: 850 g of a mixture of Japanese Pharmacopoeia ethanol (3:1) to obtain a coating liquid. Then, 3000 g of the die was placed in a coating machine (Hi-Coater HCT-48, FREUND industry), and the coating was applied until the mass of the die increased by 10 mg per piece, and the mass per piece was 220. Mg coated film (film thickness 64.5 μm: n = 10 average, image analysis method).
將3000 g之以與實施例1相同的方式獲得之裸片放入包衣機(Hi-Coater HCT-48、FREUND產業),使用將80 g之羥丙基甲纖維素2910(TC-5RW:信越化學工業製造)溶解於純化水:日本藥典乙醇(3:1)混合液920 g中所得之包膜液,進行包衣直至裸片每1片質量增加量達到10 mg為止,獲得每1片質量之為220 mg之包膜片(衣膜厚度為62.9 μm:n=10之平均、圖像解析法)。3000 g of the obtained die in the same manner as in Example 1 was placed in a coating machine (Hi-Coater HCT-48, FREUND industry), and 80 g of hydroxypropylmethylcellulose 2910 (TC-5RW: It is dissolved in purified water: the coating liquid obtained in 920 g of the Japanese Pharmacopoeia ethanol (3:1) mixture, and coated until the mass of the bare piece reaches 10 mg per piece, and each piece is obtained. A mass of 220 mg of the envelope (film thickness of 62.9 μm: n = 10 average, image analysis method).
使用4.8 kg之鹽酸苯海拉明(金剛化學製造)、4.8 kg之甘胺酸(協和醱酵製造)、6.36 kg之乳糖(Tablettose 80:Meggle Japan製造)、19.2 kg之結晶纖維素(Ceolus KG-802:旭化成化學製造)、1152 g之低取代羥丙基纖維素(L-HPC LH-11:信越化學工業製造)、960 g之交聯羧甲纖維素鈉(Kiccolate:旭化成化學製造)、384 g之輕質無水矽酸(Adsolider 101:FREUND產業製造)、384 g之硬脂酸鎂(太 平化學製造)及384 g之滑石(Kihara Kasei製造),製造壓片用混合粉,利用旋轉式壓片機(VIRGO-0512型壓片機:菊水製作所製造),以9 mmΦ之研缽棒進行壓片,直至每1片質量達到200 mg為止,獲得約37.5 kg之裸片。其次,將36 g之羥丙基甲纖維素2910(TC-5RW:信越化學工業製造)、8 g之聚乙二醇6000(日本油脂製造)、69 g之滑石(勝光山礦業所:平均粒徑為4.6 μm、粒度45 μm篩餘量為0.1%、白度為93.6%)、24 g之氧化鈦(石原產業製造),溶解.懸浮於純化水863 g中,從而獲得包膜液。繼而,將3 kg之裸片放入包衣機(Hi-Coater HCT-48、FREUND產業),進行包衣直至裸片每1片質量增加量達到10 mg為止,獲得每1片之質量為210 mg之包膜片(衣膜厚度為65.7 μm:n=10之平均、圖像解析法)。4.8 kg of diphenhydramine hydrochloride (manufactured by King Kong Chemical Co., Ltd.), 4.8 kg of glycine (manufactured by Kyowa Mastic), 6.36 kg of lactose (Tablettose 80: manufactured by Megle Japan), and 19.2 kg of crystalline cellulose (Ceolus KG) -802: manufactured by Asahi Kasei Chemicals Co., Ltd., 1152 g of low-substituted hydroxypropylcellulose (L-HPC LH-11: manufactured by Shin-Etsu Chemical Co., Ltd.), 960 g of croscarmellose sodium (Kiccolate: manufactured by Asahi Kasei Chemicals), 384 g of light anhydrous citric acid (Adsolider 101: manufactured by FREUND), 384 g of magnesium stearate (too Manufactured into a talc of 384 g (manufactured by Kihara Kasei), a mixed powder for tableting, using a rotary tablet press (VIRGO-0512 tablet press: manufactured by Kikusui Seisakusho Co., Ltd.), with a 9 mm Φ mortar rod Tablets were pressed until a mass of 200 mg per sheet was obtained, and a bare piece of about 37.5 kg was obtained. Next, 36 g of hydroxypropylmethylcellulose 2910 (TC-5RW: manufactured by Shin-Etsu Chemical Co., Ltd.), 8 g of polyethylene glycol 6000 (manufactured by Nippon Oil & Fats Co., Ltd.), and 69 g of talc (Shengguangshan Mining Institute: average grain) The diameter is 4.6 μm, the particle size is 45 μm, the residual amount is 0.1%, the whiteness is 93.6%), and 24 g of titanium oxide (manufactured by Ishihara Industry Co., Ltd.) is dissolved. It was suspended in 863 g of purified water to obtain a coating liquid. Then, a 3 kg piece of the die was placed in a coating machine (Hi-Coater HCT-48, FREUND industry), and the coating was applied until the mass of the die reached 10 mg per piece, and the mass per piece was 210. Mg coated film (film thickness 65.7 μm: n = 10 average, image analysis method).
藉由調整實施例2之包膜液,將聚乙二醇6000變更為10 g且將純化水變更為861 g,以與實施例2相同之方式獲得包膜液,並以與實施例2相同之方式對3 kg的實施例2中製造之裸片進行包衣,獲得本發明之每1片之質量為210 mg之包膜片(衣膜厚度為65.4 μm)。The coating liquid was obtained in the same manner as in Example 2 by adjusting the coating liquid of Example 2, changing the polyethylene glycol 6000 to 10 g and changing the purified water to 861 g, and the same as in Example 2. In the manner of 3 kg of the die manufactured in Example 2, a coated film of a mass of 210 mg (film thickness of 65.4 μm) per one piece of the present invention was obtained.
藉由調整實施例2之包膜液,將聚乙二醇6000變更為13 g且將純化水變更為858 g,以與實施例2相同之方式獲得包膜液,並以與實施例2相同之方式對3 kg的實施例2中製造之裸片進行包衣,獲得每1片之質量為210 mg之包膜片 (衣膜厚度65.9 μm)。The coating liquid was obtained in the same manner as in Example 2 by adjusting the coating liquid of Example 2, changing the polyethylene glycol 6000 to 13 g and changing the purified water to 858 g, and the same as in Example 2. 3 kg of the die fabricated in Example 2 was coated to obtain a 210 mg mass of the coated film per piece. (film thickness 65.9 μm).
藉由調整實施例2之包膜液,將聚乙二醇6000變更為15 g且將純化水變更為856 g,以與實施例2相同之方式獲得包膜液,並以與實施例2相同之方式對3 kg的實施例2中製造之裸片進行包衣,獲得每1片之質量為210 mg之包膜片(衣膜厚度為63.9 μm)。The coating liquid was obtained in the same manner as in Example 2 by adjusting the coating liquid of Example 2, changing the polyethylene glycol 6000 to 15 g and changing the purified water to 856 g, and the same as in Example 2. In the manner of 3 kg of the die manufactured in Example 2, a coated film having a mass of 210 mg per film (film thickness of 63.9 μm) was obtained.
藉由調整實施例2之包膜液,將聚乙二醇6000變更為21 g且將純化水變更為850 g,以與實施例2相同之方式獲得包膜液,並以與實施例2相同之方式對3 kg的實施例2中製造之裸片進行包衣,獲得每1片之質量為210 mg之包膜片(衣膜厚度65.8 μm)。The coating liquid was obtained in the same manner as in Example 2 by adjusting the coating liquid of Example 2, changing the polyethylene glycol 6000 to 21 g and changing the purified water to 850 g, and the same as in Example 2. In the manner of 3 kg of the die manufactured in Example 2, a coated film having a mass of 210 mg per film (film thickness: 65.8 μm) was obtained.
藉由調整實施例2之包膜液,將聚乙二醇6000變更為28 g且將純化水變更為843 g,以與實施例2相同之方式獲得包膜液,並以與實施例2相同之方式對3 kg在實施例2中製造之裸片進行包衣,獲得每1片之質量為210 mg之包膜片(衣膜厚度為64.4 μm)。The coating liquid was obtained in the same manner as in Example 2 by adjusting the coating liquid of Example 2, changing the polyethylene glycol 6000 to 28 g and changing the purified water to 843 g, and the same as in Example 2. In the manner of 3 kg of the die manufactured in Example 2, a coated film having a mass of 210 mg per film (film thickness of 64.4 μm) was obtained.
藉由調整實施例2之包膜液,將聚乙二醇6000變更為35 g且將純化水變更為836 g,以與實施例2相同之方式獲得包膜液,並以與實施例2相同之方式對3 kg的實施例2中製造之裸片進行包衣,獲得本發明之每1片之質量為210 mg 之包膜片(衣膜厚度為65.7 μm)。The coating liquid was obtained in the same manner as in Example 2 by adjusting the coating liquid of Example 2, changing the polyethylene glycol 6000 to 35 g and changing the purified water to 836 g, and was the same as in Example 2. In the manner of 3 kg of the die manufactured in Example 2, the mass of each of the tablets of the present invention was 210 mg. The envelope film (film thickness is 65.7 μm).
藉由調整實施例2之包膜液,將聚乙二醇6000變更為40 g且將純化水變更為831 g,以與實施例2相同之方式獲得包膜液,並以與實施例2相同之方式對3 kg的實施例2中製造之裸片進行包衣,獲得每1片之質量為210 mg之包膜片(衣膜厚度為66.1 μm)。The coating liquid was obtained in the same manner as in Example 2 by adjusting the coating liquid of Example 2, changing the polyethylene glycol 6000 to 40 g and changing the purified water to 831 g, and the same as in Example 2. In the manner of 3 kg of the die fabricated in Example 2, a coated film having a mass of 210 mg per film (film thickness of 66.1 μm) was obtained.
藉由調整實施例2之包膜液,將聚乙二醇6000變更為43 g且將純化水變更為828 g,以與實施例2相同之方式獲得包膜液,並以與實施例2相同之方式對3 kg的實施例2中製造之裸片進行包衣,獲得每1片之質量為210 mg之包膜片(衣膜厚度65.8 μm)。The coating liquid was obtained in the same manner as in Example 2 by adjusting the coating liquid of Example 2, changing the polyethylene glycol 6000 to 43 g and changing the purified water to 828 g, and the same as in Example 2. In the manner of 3 kg of the die manufactured in Example 2, a coated film having a mass of 210 mg per film (film thickness: 65.8 μm) was obtained.
藉由調整實施例2之包膜液,將聚乙二醇6000變更為45 g且將純化水變更826 g,以與實施例2相同之方式獲得包膜液,並以與實施例2相同之方式對3 kg的實施例2中製造之裸片進行包衣,獲得每1片質量為210 mg之包膜片(衣膜厚度66.3 μm)。The coating liquid was obtained in the same manner as in Example 2 by adjusting the coating liquid of Example 2, changing the polyethylene glycol 6000 to 45 g and changing the purified water to 826 g, and the same as in Example 2. Membrane 3 kg of the die fabricated in Example 2 was coated to obtain a coated film of 210 mg each (film thickness 66.3 μm).
藉由調整實施例2之包膜液,將聚乙二醇6000變更為5 g且將純化水變更為866 g,以與實施例2相同之方式獲得包膜液,並與實施例2相同之方式對3 kg的實施例2中製造之裸片進行包衣,獲得每1片之質量為210 mg之包膜片(衣膜 厚度為63.7 μm)。The coating liquid was obtained in the same manner as in Example 2 by adjusting the coating liquid of Example 2, changing the polyethylene glycol 6000 to 5 g and changing the purified water to 866 g, and the same as in Example 2. Method 3 kg of the die fabricated in Example 2 was coated to obtain a film of 210 mg per film (film film) The thickness is 63.7 μm).
藉由調整實施例2之包膜液,將聚乙二醇6000變更為60 g且將純化水變更為811 g,以與實施例2相同之方式獲得包膜液,並以與實施例2相同之方式對3 kg的實施例2中製造之裸片進行包衣,獲得每1片之質量為210 mg之包膜片(衣膜厚度63.7 μm)。The coating liquid was obtained in the same manner as in Example 2 by adjusting the coating liquid of Example 2, changing the polyethylene glycol 6000 to 60 g and changing the purified water to 811 g, and the same as in Example 2. In the manner of 3 kg of the die manufactured in Example 2, a coated film having a mass of 210 mg per film (film thickness: 63.7 μm) was obtained.
按照以下5個等級,評價實施例1~11及比較例1~3之包膜片之表面光澤。將其結果示於表1。The surface gloss of the coated sheets of Examples 1 to 11 and Comparative Examples 1 to 3 was evaluated in accordance with the following five grades. The results are shown in Table 1.
由表1所明示,本發明之片劑可獲得相較於比較例更高之光澤。As is evident from Table 1, the tablets of the present invention were able to obtain a higher gloss than the comparative examples.
無光澤:-僅有一點光澤:±有光澤:+有較強光澤:++有非常強烈之光澤:+++Matte: - only a little gloss: ± shiny: + has a strong gloss: ++ has a very strong luster: +++
使用7.2 kg之布洛芬(BASF日本製造)、11.136 kg之乳糖(Tablettose 80:Meggle Japan製造)、16.8 kg之結晶纖維素(Ceolus KG-802:旭化成化學製造)、1152 g之低取代羥丙基纖維素(L-HPC LH-11:信越化學工業製造)、960 g之交聯羧甲纖維素鈉(Kiccolate:旭化成化學製造)、384 g之輕質無水矽酸(Adsolider 101:FREUND產業製造)、384 g之硬脂酸鎂(太平化學工業製造)及384 g之滑石(Kihara Kasei製造),製造壓片用混合粉,利用旋轉式壓片機(VIRGO-0512型壓片機:菊水製作所製造),以9 mmΦ之研缽棒進行壓片,直至每1片質量達到200 mg為止,獲得約37 kg之裸片。其次,將36 g之羥丙基甲纖維素2910(TC-5RW:信越化學工業製造)、21 g之聚乙二醇6000(日本油脂製造)、30 g之滑石(勝光山礦業所:平均粒徑為4.6 μm、粒度45 μm篩餘量為0.1%、白度為93.6%)、24 g之氧化鈦(石原產業製造),溶解.懸浮於889 g之純化水中,獲得包膜液。繼而,將3 kg之裸片放入包衣機(Hi-Coater HCT-48、FREUND產業),進行包衣直至裸片每1片質量增加量達到7.5 mg為止,獲得每1片之質量為207.5 mg之包膜片(衣膜厚度為 50.8 μm:n=10之平均、圖像解析法)。7.2 kg of ibuprofen (manufactured by BASF Japan), 11.136 kg of lactose (Tablettose 80: manufactured by Megle Japan), 16.8 kg of crystalline cellulose (Ceolus KG-802: manufactured by Asahi Kasei Chemicals), and 1152 g of low-substituted hydroxypropyl Cellulose (L-HPC LH-11: manufactured by Shin-Etsu Chemical Co., Ltd.), 960 g of croscarmellose sodium (Kiccolate: manufactured by Asahi Kasei Chemicals), 384 g of light anhydrous citric acid (Adsolider 101: manufactured by FREUND) ), 384 g of magnesium stearate (made by Taiping Chemical Industry Co., Ltd.) and 384 g of talc (manufactured by Kihara Kasei), for the production of mixed powder for tableting, using a rotary tablet press (VIRGO-0512 tablet press: Kikusui Manufacturing Co., Ltd.) Manufactured), pressed with a 9 mm Φ mortar bar until each piece reached a mass of 200 mg, and a bare piece of about 37 kg was obtained. Next, 36 g of hydroxypropylmethylcellulose 2910 (TC-5RW: manufactured by Shin-Etsu Chemical Co., Ltd.), 21 g of polyethylene glycol 6000 (manufactured by Nippon Oil & Fats Co., Ltd.), and 30 g of talc (Shengguangshan Mining Institute: average grain) The diameter is 4.6 μm, the particle size is 45 μm, the residual amount is 0.1%, the whiteness is 93.6%), and 24 g of titanium oxide (manufactured by Ishihara Industry Co., Ltd.) is dissolved. It was suspended in 889 g of purified water to obtain a coating liquid. Then, 3 kg of the die was placed in a coating machine (Hi-Coater HCT-48, FREUND industry), and the coating was applied until the mass of the die reached 7.5 mg per piece, and the mass per piece was 207.5. Mg coated film (film thickness is 50.8 μm: n=10 average, image analysis method).
藉由調整實施例12之包膜液,將滑石變更為44 g且將純化水變更為875 g,以與實施例12相同之方式獲得包膜液,並以與實施例2相同之方式對3 kg的實施例2中製造之裸片進行包衣,獲得每1片之質量為207.5 mg之包膜片(衣膜厚度為49.9 μm)。The coating liquid was obtained in the same manner as in Example 12 by adjusting the coating liquid of Example 12, changing the talc to 44 g and changing the purified water to 875 g, and in the same manner as in Example 2, The pellets produced in Example 2 of kg were coated to obtain a coated sheet having a mass of 207.5 mg per film (film thickness: 49.9 μm).
藉由調整實施例12之包膜液,將滑石變更為60 g且將純化水變更為859 g,以與實施例12相同之方式獲得包膜液,並以與實施例2相同之方式對3 kg的實施例2中製造之裸片進行包衣,獲得每1片之質量為207.5 mg之包膜片(衣膜厚度為51.4 μm)。The coating liquid was obtained in the same manner as in Example 12 by adjusting the coating liquid of Example 12, changing the talc to 60 g and changing the purified water to 859 g, and in the same manner as in Example 2, The pellets produced in Example 2 of kg were coated to obtain a coated sheet having a mass of 207.5 mg per film (film thickness: 51.4 μm).
藉由調整實施例12之包膜液,將滑石變更為69 g且將純化水變更為850 g,以與實施例12相同之方式獲得包膜液,並以與實施例2相同之方式對3 kg的實施例2中製造之裸片進行包衣,獲得每1片之質量為207.5 mg之包膜片(衣膜厚度為50.1 μm)。The coating liquid was obtained in the same manner as in Example 12 by adjusting the coating liquid of Example 12, changing the talc to 69 g and changing the purified water to 850 g, and in the same manner as in Example 2, The pellets produced in Example 2 of kg were coated to obtain a coated sheet having a mass of 207.5 mg per film (film thickness: 50.1 μm).
藉由調整實施例12之包膜液,將滑石變更為85 g且將純化水變更為834 g,以與實施例12相同之方式獲得包膜液,並以與實施例2相同之方式對3 kg的實施例2中製造之裸片進行包衣,獲得每1片之質量為207.5 mg之包膜片(衣 膜厚度為53.8 μm)。The coating liquid was obtained in the same manner as in Example 12 by adjusting the coating liquid of Example 12, changing the talc to 85 g and changing the purified water to 834 g, and in the same manner as in Example 2, The pellets produced in Example 2 of kg were coated to obtain a coated sheet of 207.5 mg mass per sheet. The film thickness is 53.8 μm).
藉由調整實施例12之包膜液,將滑石變更為105 g且將純化水變更為1014 g,以與實施例12相同之方式獲得包膜液,並以與實施例2相同之方式對3 kg的實施例2中製造之裸片進行包衣,獲得每1片之質量為207.5 mg之包膜片(衣膜厚度為51.7 μm)。The coating liquid was obtained in the same manner as in Example 12 by adjusting the coating liquid of Example 12, changing the talc to 105 g and changing the purified water to 1014 g, and in the same manner as in Example 2, The pellets produced in Example 2 of kg were coated to obtain a coated sheet having a mass of 207.5 mg per film (film thickness: 51.7 μm).
藉由調整實施例12之包膜液,將滑石變更為135 g且將純化水變更為984 g,以與實施例12相同之方式獲得包膜液,並以與實施例2相同之方式對3 kg的實施例2中製造之裸片進行包衣,獲得每1片之質量為207.5 mg之包膜片(衣膜厚度為51.9 μm)。The coating liquid was obtained in the same manner as in Example 12 by adjusting the coating liquid of Example 12, changing the talc to 135 g and changing the purified water to 984 g, and in the same manner as in Example 2, The pellets produced in Example 2 of kg were coated to obtain a coated sheet having a mass of 207.5 mg per film (film thickness: 51.9 μm).
藉由調整實施例12之包膜液,將滑石變更為10 g且將純化水變更為909 g,以與實施例12相同之方式獲得包膜液,並以與實施例2相同之方式對3 kg的實施例2中製造之裸片進行包衣,獲得每1片之質量為207.5 mg之包膜片(衣膜厚度為51.9 μm)。The coating liquid was obtained in the same manner as in Example 12 by adjusting the coating liquid of Example 12, changing the talc to 10 g and changing the purified water to 909 g, and in the same manner as in Example 2, The pellets produced in Example 2 of kg were coated to obtain a coated sheet having a mass of 207.5 mg per film (film thickness: 51.9 μm).
藉由調整實施例12之包膜液,將滑石變更為180 g且將純化水變更為1239 g,以與實施例12相同之方式獲得包膜液,並以與實施例2相同之方式對3 kg的實施例2中製造之裸片進行包衣,獲得每1片質量為207.5 mg之包膜片(衣膜 厚度為52.1 μm)。The coating liquid was obtained in the same manner as in Example 12 by adjusting the coating liquid of Example 12, changing the talc to 180 g and changing the purified water to 1239 g, and in the same manner as in Example 2, The pellets produced in Example 2 of kg were coated to obtain a coated film of 207.5 mg each. The thickness is 52.1 μm).
與試驗例1相同之方式,按照5個等級來評價實施例12~18及比較例4~5之包膜片之表面光澤,將其結果示於表2中。由表2所明示,本發明之片劑獲可獲得相較於比較例更高之光澤。In the same manner as in Test Example 1, the surface gloss of the coated sheets of Examples 12 to 18 and Comparative Examples 4 to 5 was evaluated in five grades, and the results are shown in Table 2. As evident from Table 2, the tablets of the present invention were obtained with higher gloss than the comparative examples.
使用2.4 kg之L-半胱胺酸(協和醱酵製造)、1.5 kg之抗壞血酸(BASF日本製造)、1.5 kg之鹽酸吡哆醇(第一精密化學製造)、1.2 kg之菸鹼醯胺(DSM NUTRITIONAL製造)、1.14 kg之磷酸核黃素鈉(岩城製藥製造)、300 g之硝酸硫胺(武田藥品製造)、3 g之生物素(SUN CHEMICAL製造)、30 g之玉米澱粉(SAN-A糖化製造)、2.547 kg之結晶纖維素(旭化成化學製造)、1.2 kg之羥丙基纖維素(日本曹達製造)、660 g之低取代羥丙基纖維素(信越化學工業製造)、60 g之硬脂酸鎂(太平化學工業製造)、60 g之滑石(Kihara Kasei 製造),利用常法製造壓片用粉末,利用旋轉式壓片機,以9 mmΦ之研缽棒對所得之混合粉進行壓片,直至每1片質量達到210 mg為止,獲得裸片。其次,將3 kg之該裸片放入包衣機(Hi-Coater HCT-48、FREUND產業),使用含有20質量%之Opadry AMB White(聚乙烯醇之預混劑:日本COLORCON製造)之純化水包衣液,進行底層包衣直至每1片質量增加量達到7 mg為止,繼而,使用含有8質量%的泛酸鈣(ALPS藥品工業製造)、8質量%的羥丙基甲纖維素2910(TC-5信越化學工業製造)之乙基醇:純化水=1:1的包衣液,進行底層包衣直至每1片質量增加量達到20 mg為止,獲得每1片之質量為237 mg之經底層包衣之包膜片。2.4 kg of L-cysteine (manufactured by Kyowa Mastic), 1.5 kg of ascorbic acid (BASF made in Japan), 1.5 kg of pyridoxine hydrochloride (manufactured by First Precision Chemical Co., Ltd.), 1.2 kg of nicotine guanamine (1.2 kg) Made by DSM NUTRITIONAL), 1.14 kg of riboflavin sodium phosphate (manufactured by Iwao Pharmaceutical Co., Ltd.), 300 g of thiamine nitrate (manufactured by Takeda Pharmaceutical Co., Ltd.), 3 g of biotin (manufactured by SUN CHEMICAL), and 30 g of corn starch (SAN- A saccharification manufacturing), 2.547 kg of crystalline cellulose (manufactured by Asahi Kasei Chemicals), 1.2 kg of hydroxypropyl cellulose (manufactured by Japan Soda), 660 g of low-substituted hydroxypropyl cellulose (manufactured by Shin-Etsu Chemical Co., Ltd.), 60 g Magnesium stearate (made by Taiping Chemical Industry), 60 g of talc (Kihara Kasei) Manufactured, the powder for tableting was produced by a conventional method, and the obtained mixed powder was tableted by a rotary tableting machine with a 9 mm Φ mortar bar until the mass of each piece reached 210 mg, and a bare piece was obtained. Next, 3 kg of the die was placed in a coating machine (Hi-Coater HCT-48, FREUND industry), and purified using 20% by mass of Opadry AMB White (premix of polyvinyl alcohol: manufactured by COLORCON, Japan). The water-coating liquid was subjected to the undercoating until the mass increase amount of each of the tablets reached 7 mg, and then, 8% by mass of calcium pantothenate (manufactured by ALPS Pharmaceutical Industries) and 8 mass% of hydroxypropylmethylcellulose 2910 (using 8%) were used. Ethyl alcohol of TC-5 Shin-Etsu Chemical Co., Ltd.): a coating solution of purified water = 1:1, and coating the bottom layer until the mass increase of each tablet reaches 20 mg, and the mass per piece is 237 mg. The coated film is coated with the bottom layer.
其次,將36 g之羥丙基甲纖維素2910(TC-5RW:信越化學工業製造)、21 g之聚乙二醇6000(日本油脂製造)、30 g之滑石(勝光山礦業所:平均粒徑為4.6 μm、粒度45 μm篩餘量為0.1%、白度為93.6%)、24 g之氧化鈦(石原產業製造),溶解.懸浮於889 g之純化水中,獲得包膜液。繼而,將3 kg的經底層包衣之包膜片放入包衣機(Hi-Coater HCT-48、FREUND產業),進行包衣直至片劑每1片之質量增加量達到8 mg為止,獲得每1片之質量為245 mg之包膜片(衣膜厚度為53.4 μm:n=10之平均、圖像解析法)。Next, 36 g of hydroxypropylmethylcellulose 2910 (TC-5RW: manufactured by Shin-Etsu Chemical Co., Ltd.), 21 g of polyethylene glycol 6000 (manufactured by Nippon Oil & Fats Co., Ltd.), and 30 g of talc (Shengguangshan Mining Institute: average grain) The diameter is 4.6 μm, the particle size is 45 μm, the residual amount is 0.1%, the whiteness is 93.6%), and 24 g of titanium oxide (manufactured by Ishihara Industry Co., Ltd.) is dissolved. It was suspended in 889 g of purified water to obtain a coating liquid. Then, 3 kg of the undercoated coated film was placed in a coating machine (Hi-Coater HCT-48, FREUND industry), and the coating was applied until the mass increase of each tablet reached 8 mg. Each piece of the mass of 245 mg of the coated film (film thickness of 53.4 μm: n = 10 average, image analysis method).
將3 kg的實施例19中製造之裸片放入包衣機(Hi-Coater HCT-48、FREUND產業),以與實施例19相同之方式進行雙重底層包衣,獲得每1片之質量為237 mg之經底層包衣 之包膜片。繼而,利用實施例19中製造之本發明組合物之塗包衣,進行包衣直至片劑每1片之質量增加量達到1 mg為止,獲得每1片之質量為238 mg之包膜片(衣膜厚度為6.5 μm)。3 kg of the dies manufactured in Example 19 were placed in a coating machine (Hi-Coater HCT-48, FREUND Industries), and a double undercoat was applied in the same manner as in Example 19, and the mass per one piece was obtained. 237 mg bottom coat The envelope film. Then, using the coating of the composition of the present invention produced in Example 19, the coating was applied until the mass increase per tablet of the tablet reached 1 mg, and a coated tablet having a mass of 238 mg per tablet was obtained ( The film thickness is 6.5 μm).
將3 kg的實施例19中製造之裸片放入包衣機(Hi-Coater HCT-48、FREUND產業),以與實施例19相同之方式進行雙重底層包衣,獲得每1片之質量為237 mg的經底層包衣之包膜片。繼而,利用實施例19中製造之本發明組合物之包衣液,進行包衣直至片劑每1片之質量增加量達到3 mg為止,獲得每1片質量為240 mg之包膜片(衣膜厚度為20.7 μm)。3 kg of the dies manufactured in Example 19 were placed in a coating machine (Hi-Coater HCT-48, FREUND Industries), and a double undercoat was applied in the same manner as in Example 19, and the mass per one piece was obtained. 237 mg of the undercoated coating. Then, using the coating liquid of the composition of the present invention produced in Example 19, the coating was applied until the mass increase per tablet of the tablet reached 3 mg, and a film of 240 mg per piece was obtained. The film thickness was 20.7 μm).
將3 kg的實施例19中製造之裸片放入包衣機(Hi-Coater HCT-48、FREUND產業),以與實施例19相同之方式進行雙重底層包衣,獲得每1片之質量為237 mg的經底層包衣之包膜片。繼而,利用實施例19中製造之本發明組合物之塗層液,進行包衣直至片劑每1片之質量增加量達到5 mg為止,獲得每1片質量之為242 mg的本發明之包膜片(衣膜厚度為32.9 μm)。3 kg of the dies manufactured in Example 19 were placed in a coating machine (Hi-Coater HCT-48, FREUND Industries), and a double undercoat was applied in the same manner as in Example 19, and the mass per one piece was obtained. 237 mg of the undercoated coating. Then, using the coating liquid of the composition of the present invention produced in Example 19, the coating was applied until the mass increase per tablet of the tablet reached 5 mg, and the package of the present invention having a mass of 242 mg per tablet was obtained. Diaphragm (film thickness 32.9 μm).
以與試驗例1相同之方式,按照5個等級來評價實施例19~21及比較例6之包膜片之表面光澤,將其結果示於表3中。由表3所明示,本發明之片劑可獲得相較於比較例更 高之光澤。The surface gloss of the coated sheets of Examples 19 to 21 and Comparative Example 6 was evaluated in five stages in the same manner as in Test Example 1, and the results are shown in Table 3. As is clear from Table 3, the tablets of the present invention can be obtained more than the comparative examples. High gloss.
Claims (8)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2007039239A JP5162141B2 (en) | 2007-02-20 | 2007-02-20 | Film coating composition |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TW200950820A TW200950820A (en) | 2009-12-16 |
| TWI404546B true TWI404546B (en) | 2013-08-11 |
Family
ID=39779588
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW97121436A TWI404546B (en) | 2007-02-20 | 2008-06-09 | Coating composition |
Country Status (2)
| Country | Link |
|---|---|
| JP (1) | JP5162141B2 (en) |
| TW (1) | TWI404546B (en) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPWO2011027728A1 (en) * | 2009-09-02 | 2013-02-04 | 日本曹達株式会社 | Coating agent containing hydroxyalkyl cellulose |
| SI2508206T1 (en) * | 2009-11-30 | 2014-09-30 | Toray Industries, Inc. | Film coating agent for solid preparation, and solid preparation using same |
| JP5806490B2 (en) * | 2011-03-31 | 2015-11-10 | エスエス製薬株式会社 | Film coating composition |
| JP5608626B2 (en) | 2011-11-04 | 2014-10-15 | 信越化学工業株式会社 | Film coating composition and oral solid preparation |
| WO2013175303A1 (en) | 2012-05-21 | 2013-11-28 | Capsugel Belgium Nv | Acid resistant banding solution for two piece hard capsules |
| MX2016006742A (en) * | 2013-12-03 | 2016-08-12 | Hoffmann La Roche | Pharmaceutical composition. |
| FR3069545B1 (en) * | 2017-07-27 | 2020-10-16 | Soc Dexploitation De Produits Pour Les Industries Chimiques Seppic | TITANIUM DIOXIDE FREE COATING COMPOSITION |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0753262A2 (en) * | 1995-07-13 | 1997-01-15 | Mitsubishi Chemical Corporation | Coating composition for preparing solid preparations and solid preparations |
| US20020103285A1 (en) * | 1999-07-09 | 2002-08-01 | Martin Philip Jordan | Film coatings and film coating compositions based on polyvinyl alcohol |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4867983A (en) * | 1987-02-20 | 1989-09-19 | Mcneilab, Inc. | Method for double dipping gelating coated caplets |
| JPH08109126A (en) * | 1994-10-07 | 1996-04-30 | Amano Pharmaceut Co Ltd | Impact resistant enteric coated granules and tablets containing the same |
| JP2002087963A (en) * | 2000-09-08 | 2002-03-27 | Nippon Boehringer Ingelheim Co Ltd | Epinastine-containing tablets manufactured by direct compression |
| JP2003104887A (en) * | 2001-09-28 | 2003-04-09 | Maruko Seiyaku Kk | Aranidipine-containing composition stable to light |
| TWI252111B (en) * | 2001-12-14 | 2006-04-01 | Solvay Pharm Gmbh | Matrix film tablet with controlled release of a natural mixture of conjugated estrogens |
| EP1350512A1 (en) * | 2002-04-03 | 2003-10-08 | BOEHRINGER INGELHEIM INTERNATIONAL GmbH | Combinations of epinastine, belladonna and pseudoephedrine as new pharmaceutical formulations |
| JP2006188490A (en) * | 2004-12-06 | 2006-07-20 | Freunt Ind Co Ltd | Film coating composition, film and tablet thereof |
-
2007
- 2007-02-20 JP JP2007039239A patent/JP5162141B2/en active Active
-
2008
- 2008-06-09 TW TW97121436A patent/TWI404546B/en active
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0753262A2 (en) * | 1995-07-13 | 1997-01-15 | Mitsubishi Chemical Corporation | Coating composition for preparing solid preparations and solid preparations |
| US20020103285A1 (en) * | 1999-07-09 | 2002-08-01 | Martin Philip Jordan | Film coatings and film coating compositions based on polyvinyl alcohol |
Also Published As
| Publication number | Publication date |
|---|---|
| TW200950820A (en) | 2009-12-16 |
| JP5162141B2 (en) | 2013-03-13 |
| JP2008201713A (en) | 2008-09-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI404546B (en) | Coating composition | |
| JP2015221826A (en) | Pharmaceutical composition containing irbesartan and amlodipine or salt thereof | |
| JP2008201711A (en) | Solid formulation with reduced cysteine odor | |
| US20050214388A1 (en) | Multivitamin formulations containing controlled-release magnesium | |
| EP3437645A1 (en) | Film-coated tablet having high chemical stability of active ingredient | |
| KR102483142B1 (en) | Multi-vitamins complex composition with improved compliance through size reduction for formulation using iLet(innovative Low excipient tablet) technology and preparation method for the same | |
| WO2016163460A1 (en) | Tablet composition, and method for improving disintegration properties and elution properties of tablet composition | |
| JP7704933B2 (en) | Nilotinib tablets | |
| JP5806490B2 (en) | Film coating composition | |
| KR20180102966A (en) | Multivitamin composition with excellent in vivo absorption and stability comprising benfotiamine | |
| TWI414287B (en) | Compression molded preparation | |
| JP2014221847A (en) | Sugar-coated preparation and method for producing the same | |
| TW200950819A (en) | Film-coated preparation | |
| KR101498639B1 (en) | Composition for film-coating | |
| CN101632649B (en) | Composition for film coating | |
| JP5744412B2 (en) | Furosemide formulation | |
| HK1139047B (en) | Film coating composition | |
| JP7776274B2 (en) | Nilotinib tablets and their manufacturing method | |
| AU2015101120A4 (en) | Formulation for oral administration | |
| JP2019210262A (en) | Orally disintegrating tablet | |
| JP7776275B2 (en) | Nilotinib tablets and their manufacturing method | |
| KR20100000605A (en) | A cysteine smell-reduced solid preparation | |
| CN116138458A (en) | Compound vitamin tablet and preparation method thereof | |
| KR20170001786A (en) | Preparation method for pharmaceutical composition comprising Pelargonium sidoides extracts | |
| WO2026019379A1 (en) | A pharmaceutical composition comprising vitamin b |